Spondylolisthesis/Spondylolysis

M13_SPONDYLOLISTHESIS

spondylolisthesis: A condition in which there is forward displacement of a vertebral bone over the on below it.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — M43.0, M43.1 Hospital discharge: ICD-9 — 7384 Cause of death: ICD-10 — M43.0, M43.1 Cause of death: ICD-9 — 7384 2 out of 7 registries used, show all original rules.	8211
4. Check minimum number of events None	8211
5. Include endpoints None	8211
6. Filter based on genotype QC (FinnGen only)	8211

Control definitions (FinnGen only)

Control exclude: M13_DORSOPATHY

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2

NAME	M13_SPONDYLOLISTHESIS
CONTROL_EXCLUDE	M13_DORSOPATHY
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	M43[0-1]
HD_ICD_9	7384
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	M43[0-1]
COD_ICD_9	7384
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Spondylolisthesis/Spondylolysis based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	48651	28486	20045
Only index persons	47184	27814	19370
Unadjusted period prevalence (%)
Whole population	0.71	0.82	0.56
Only index persons	0.91	1.02	0.74
Median age at first event (years)
Whole population	54.63	57.47	50.61
Only index persons	54.46	57.28	50.41

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	8211	5300	2911
Unadjusted period prevalence (%)	1.62	1.81	1.28
Median age at first event (years)	57.09	57.57	56.21

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
7270: Matched controls
72700

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

72.3

323.0

2338

474

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

50.7

323.0

840

187

M47.9

ICD-10 Finland

Spondylosis, unspecified

64.0

323.0

529

N02BE01

ATC

paracetamol; systemic, rectal

4.3

323.0

6648

51793

NAG62

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, 2-3 vertebraea

3493.3

323.0

1470

M43.0

ICD-10 Finland

Spondylolysis

1946.6

323.0

2622

M54.4

ICD-10 Finland

Lumbago with sciatica

14.7

323.0

2494

2489

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

75.6

323.0

1495

248

M54.9

ICD-10 Finland

Dorsalgia, unspecified

8.1

323.0

1052

1492

L03

ICPC

Low back symptom/complaint

6.1

323.0

2944

7337

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

3.4

323.0

4131

20428

NA7EA

NOMESCO Finland

Scoliosis X-ray examination

163.6

323.0

460

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

15.6

323.0

575

398

N06AX21

ATC

duloxetine; oral

5.5

323.0

1242

2632

M47.82

ICD-10 Finland

Other spondylosis, cervical region

41.0

323.0

665

178

M43.1

ICD-10 Finland

Spondylolisthesis

3662.5

323.0

6178

109

N03AX12

ATC

gabapentin; oral

12.4

323.0

2531

3004

M54.5

ICD-10 Finland

Low back pain

7.0

323.0

3618

9019

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

45.3

323.0

705

172

M54.1

ICD-10 Finland

Radiculopathy

22.3

323.0

485

232

N02AX02

ATC

tramadol; systemic, rectal

5.1

323.0

4326

16162

ABC56

NOMESCO Finland

Decompression of lumbar spinal canal and nerve roots

3083.7

323.0

854

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

9.0

323.0

1626

2246

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

530.1

323.0

1525

M01AH05

ATC

etoricoxib; oral

3.1

323.0

5022

30300

ZZH21

NOMESCO Finland

Graft of patients own bone, small pieces

24.4

323.0

745

338

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

195.6

323.0

1276

L86

ICPC

Back syndrome with radiating pain

12.6

323.0

862

770

N02AJ06

ATC

codeine and paracetamol; systemic

3.2

323.0

3302

15036

M54.3

ICD-10 Finland

Sciatica

13.2

323.0

632

521

M48.0

ICD-10 Finland

Spinal stenosis

226.0

323.0

3143

244

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

75.1

323.0

2189

415

M03BX02

ATC

tizanidine; oral

2.9

323.0

5039

31563

N03AX16

ATC

pregabalin; oral

8.5

323.0

3225

6220

NAG66

NOMESCO Finland

Posterior interbody fusion of lumbar spine, 2 vertebrae

+∞

323.0

561

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

865.0

323.0

1514

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

34.0

323.0

2536

1127

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

36.0

323.0

431

127

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

2.9

309.5

2563

11642

NAG65

NOMESCO Finland

Anterior and posterior fusion of lumbar spine

+∞

289.5

276

N06AA09

ATC

amitriptyline; systemic

4.8

288.2

1069

2531

M79.6

ICD-10 Finland

Pain in limb

2.6

286.1

2919

14854

M01AC06

ATC

meloxicam; systemic, rectal

2.5

278.5

3145

16860

M03BC01

ATC

orphenadrine (citrate); systemic

3.0

274.6

1968

8021

M96.1

ICD-10 Finland

Postlaminectomy syndrome, not elsewhere classified

1309.1

260.8

253

ZXM20

NOMESCO Finland

Intraoperative use of computerised tomography

75.3

260.2

297

M01AB05

ATC

diclofenac; systemic, rectal

2.4

260.2

5123

36023

NAG40

NOMESCO Finland

Anterior fusion of cervical spine without fixation

875.6

259.9

254

ZZH40

NOMESCO Finland

Substitute of bone

37.9

258.3

333

M01AH01

ATC

celecoxib; oral (coxibs)

3.1

257.3

1675

6354

A02BC02

ATC

pantoprazole; systemic

2.4

255.5

4975

34602

NAG63

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, more than 3 vertebraea

487.5

238.7

237

M75.1

ICD-10 Finland

Rotator cuff syndrome

2.7

234.9

1978

8783

ABC16

NOMESCO Finland

Microsurgical excision of lumbar intervertebral disc displacement

772.1

229.5

225

M25.5

ICD-10 Finland

Pain in joint

2.5

225.2

2312

11438

A02BC05

ATC

esomeprazole; systemic

2.3

221.3

3204

18789

G55.1*M51.1

ICD-10 Finland

Compression of nerve roots and nerve plexus in disc diseases in the lumbar region and other regions

59.4

218.2

258

M70.6

ICD-10 Finland

Trochanteric bursitis

3.5

218.1

1156

3719

M53.2

ICD-10 Finland

Spinal instabilities

551.6

217.3

215

M17.1

ICD-10 Finland

Other primary gonarthrosis

2.6

208.0

1813

8123

M54.2

ICD-10 Finland

Cervicalgia

6.1

204.2

591

1032

G55.2*M47.9

ICD-10 Finland

Nerve root and plexus compressions in spondylosis

75.3

204.1

233

A02BC03

ATC

lansoprazole; oral

2.4

201.5

2342

12207

M53.1

ICD-10 Finland

Cervicobrachial syndrome

4.1

200.4

866

2332

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

20.3

200.1

306

157

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

5.2

198.1

664

1382

G56.0

ICD-10 Finland

Carpal tunnel syndrome

3.2

197.1

1207

4298

M19.0

ICD-10 Finland

Primary arthrosis of other joints

3.7

195.4

941

2782

WX408

NOMESCO Finland

General anesthesy, balanced

2.4

195.0

2212

11348

N02AA05

ATC

oxycodone; systemic

3.1

194.3

1216

4394

SPAT1153

SPAT

Removal of sutures

2.2

194.2

2586

14335

S18

ICPC

Laceration/cut

2.1

190.9

3216

19758

M50.3

ICD-10 Finland

Other cervical disc degeneration

37.6

183.9

237

M01AE03

ATC

ketoprofen; systemic, rectal

2.1

181.7

2852

16884

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.8

180.7

1395

5753

H02AB06

ATC

prednisolone; systemic

2.0

176.3

3408

21925

R03AC02

ATC

salbutamol; inhalant

2.0

174.7

3861

26170

NAU20

NOMESCO Finland

Removal of internal fixation device from spine or neck

155.5

172.3

182

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.1

172.1

2533

14494

7384A

ICD-9 Finland

Other acquired deformity, Acquired spondylolisthesis

+∞

171.5

164

AB5BT

NOMESCO Finland

Blockage of nerv root with X-ray guidance

432.6

170.4

170

7227C

ICD-9 Finland

Intervertebral disk disorders, Intervertebral disk disorder with myelopathy[SYNDROMA ISCHIADICUM]

+∞

167.3

160

ZXC95

NOMESCO Finland

Use of surgical navigator

15.0

166.7

285

197

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

2.0

165.3

3058

19159

M54

ICD-10 Finland

Dorsalgia

3.3

165.0

931

3095

M01AX17

ATC

nimesulide; oral

2.3

164.5

1935

9952

M01AH02

ATC

rofecoxib; oral

2.9

164.3

1133

4328

M01AE02

ATC

naproxen; oral, rectal

2.0

161.5

4100

28930

Z01.8

ICD-10 Finland

Other specified special examinations

2.4

160.4

1669

8062

M03BC51

ATC

orphenadrine, combinations; systemic

2.2

159.0

2143

11700

N06AX11

ATC

mirtazapine; oral

2.1

157.3

2377

13627

N06AX16

ATC

venlafaxine; oral

2.8

156.7

1147

4540

L13

ICPC

Hip symptom/complaint

2.6

156.5

1297

5528

R51.80

ICD-10 Finland

Headache

2.9

156.4

1100

4243

A02BC01

ATC

omeprazole; systemic

2.2

150.8

2037

11082

L28

ICPC

Limited function/disability (L)

2.7

149.5

1183

4897

ABC26

NOMESCO Finland

Open discectomy of lumbar spine

+∞

145.3

139

NA3SA

NOMESCO Finland

Lumbar spine X-ray examination in standing position

47.7

144.3

177

M01AE01

ATC

ibuprofen; systemic, rectal

2.5

144.1

6508

56319

M51.8

ICD-10 Finland

Other specified intervertebral disc disorders

154.1

142.9

151

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.1

142.7

2094

11754

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

2.8

141.0

1003

3878

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

17.0

138.6

225

136

R06.0

ICD-10 Finland

Dyspnoea

2.2

135.5

1762

9350

J01DB01

ATC

cefalexin; oral

2.0

134.3

5858

48668

L08

ICPC

Shoulder symptom/complaint

2.3

132.8

1475

7268

M41.9

ICD-10 Finland

Scoliosis, unspecified

33.8

132.7

175

R07.4

ICD-10 Finland

Chest pain, unspecified

2.1

132.4

1912

10597

M51.9

ICD-10 Finland

Intervertebral disc disorder, unspecified

64.2

129.5

151

SAA02

NOMESCO Finland

Basic examination of mouth

1.8

128.7

4512

34325

L17

ICPC

Foot/toe symptom/complaint

2.1

127.4

1849

10239

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.9

126.2

839

3092

M02AA07

ATC

piroxicam; topical

1.9

125.9

2662

17019

M47.1

ICD-10 Finland

Other spondylosis with myelopathy

189.0

124.9

130

NAG61

NOMESCO Finland

Posterior fusion of lumbar spine without fixation

+∞

124.3

119

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

7.9

123.9

296

390

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.4

122.3

1213

5625

J01AA02

ATC

doxycycline; systemic

1.9

122.3

5632

46578

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.8

120.1

3035

20531

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

2.5

119.8

1085

4794

M54.6

ICD-10 Finland

Pain in thoracic spine

4.4

119.6

467

1124

SAA01

NOMESCO Finland

Simple examination of mouth

1.8

117.4

4933

39175

WX110

NOMESCO Finland

Local anesthesy

1.8

115.8

4819

38051

L02

ICPC

Back symptom/complaint

3.1

115.7

685

2327

R52.2

ICD-10 Finland

Other chronic pain

6.4

115.3

318

515

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.8

115.2

3390

23980

NF1AA

NOMESCO Finland

Hip X-ray examination

3.1

114.6

692

2383

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.8

114.3

3727

27204

A06AC01

ATC

ispaghula (psylla seeds); oral

2.0

114.2

1785

10114

NE1AA

NOMESCO Finland

Pelvis X-ray examination

3.5

113.0

563

1679

WZA90

NOMESCO Finland

Other doctors statement

2.0

112.6

1682

9345

UJF32

NOMESCO Finland

Coloscopy

2.0

112.5

1838

10581

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

2.7

111.8

852

3403

J01DA01

ATC

[U] cefalexin; systemic

1.7

111.7

4397

33907

M79.0

ICD-10 Finland

Rheumatism, unspecified

6.0

111.0

324

565

N05CF01

ATC

zopiclone; oral

1.9

110.7

2278

14264

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

4.9

109.9

382

816

L84

ICPC

Back syndrome without radiat pain

4.6

109.6

406

926

M54.8

ICD-10 Finland

Other dorsalgia

5.9

108.7

320

564

M16.1

ICD-10 Finland

Other primary coxarthrosis

2.6

107.9

864

3549

SPAT1301

SPAT

No procedures

1.9

107.2

2202

13746

B01AB05

ATC

enoxaparin; parenteral

1.9

107.1

2200

13726

J45.9

ICD-10 Finland

Asthma, unspecified

2.2

107.1

1273

6397

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.7

106.3

3870

28940

ACC51

NOMESCO Finland

Release of median nerve

3.1

105.9

632

2154

L01

ICPC

Neck symptom/complaint

2.4

104.8

965

4275

G44.2

ICD-10 Finland

Tension-type headache

2.5

104.2

927

4035

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

3.1

103.0

607

2047

M01AX05

ATC

glucosamine; oral

2.0

103.0

1516

8331

A01

ICPC

Pain general/multiple sites

3.2

102.5

586

1936

X59

ICD-10 Finland

Exposure to unspecified factor

2.1

102.4

1308

6770

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

13.8

102.3

180

133

A02BA02

ATC

ranitidine; systemic

2.1

100.5

1389

7429

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

6.6

99.8

267

415

M01AX01

ATC

nabumetone; oral

4.2

99.5

405

1012

J01.0

ICD-10 Finland

Acute maxillary sinusitis

2.0

99.0

1494

8272

M01AB55

ATC

diclofenac, combinations; oral

3.2

99.0

565

1861

XA402

NOMESCO Finland

ENMG

7.3

98.0

246

349

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

2.0

97.3

1387

7502

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.2

96.6

1132

5625

J01FF01

ATC

clindamycin; systemic

1.9

95.6

1911

11719

L15

ICPC

Knee symptom/complaint

2.0

95.4

1522

8600

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

3.2

94.5

547

1819

M96.0

ICD-10 Finland

Pseudarthrosis after fusion or arthrodesis

28.5

94.0

129

SPAT1263

SPAT

Sampling

1.7

93.9

2887

20264

N03AE01

ATC

clonazepam; systemic

3.5

93.8

474

1425

J01MA02

ATC

ciprofloxacin; systemic

1.7

91.6

2575

17558

M79.1

ICD-10 Finland

Myalgia

2.4

91.0

865

3877

J01FA10

ATC

azithromycin; systemic

1.7

91.0

3987

30804

WX704

NOMESCO Finland

Intubation

2.9

89.9

602

2209

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.6

89.7

3932

30334

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

11.4

89.5

172

154

J01FA06

ATC

roxithromycin; oral

1.7

88.8

2820

19877

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.8

87.6

600

2232

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

3.0

87.4

556

1971

R01AD09

ATC

mometasone; nasal

1.7

86.8

3052

22091

R4110

NOMESCO Finland

Physiotherapy

1.8

85.9

1861

11648

K02.1

ICD-10 Finland

Caries of dentine

1.6

85.9

3812

29353

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

2.0

85.4

1240

6713

P01AB01

ATC

metronidazole; oral, rectal

1.7

84.4

2743

19378

TPH07

NOMESCO Finland

Cathetrisation of artery

2.4

84.4

786

3478

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

5.4

84.2

263

497

NA6BG

NOMESCO Finland

Sacro-iliac joint MRI examination with high intensity magnet

23.0

83.7

122

M79.7

ICD-10 Finland

Fibromyalgia

5.3

83.4

265

511

N02AC04

ATC

dextropropoxyphene; oral

5.3

82.7

265

516

G47.3

ICD-10 Finland

Sleep apnoea

1.9

82.6

1443

8370

R5599

NOMESCO Finland

Other rehabilitation service

6.0

82.5

239

412

M45

ICD-10 Finland

Ankylosing spondylitis

41.7

82.1

103

M16.0

ICD-10 Finland

Primary coxarthrosis, bilateral

3.0

81.2

513

1807

M48.9

ICD-10 Finland

Spondylopathy, unspecified

207.2

79.4

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.7

79.3

2014

13186

SAA03

NOMESCO Finland

Extended examination of mouth

1.7

78.4

2545

17871

SPAT1310

SPAT

Counselling related to known health issue

1.7

77.9

2154

14449

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

11.1

77.6

151

139

9183

FHL

Posterolateral spondylodesis

202.1

77.3

TPH04

NOMESCO Finland

Cathetrisation of vein

1.9

77.3

1402

8220

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.7

77.0

1863

11998

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.3

76.8

781

3603

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.3

76.8

783

3619

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

4.0

76.6

327

851

R06AE07

ATC

cetirizine; oral

1.6

76.3

2942

21581

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.0

76.0

1154

6330

N02AJ13

ATC

tramadol and paracetamol; systemic

7.1

75.7

192

277

N05BA01

ATC

diazepam; systemic, rectal

2.1

75.1

919

4615

J01CA04

ATC

amoxicillin; systemic

1.7

74.9

5506

47451

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.6

74.5

3047

22645

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.7

74.4

2279

15689

ZXA00

NOMESCO Finland

Right side

1.7

74.2

1842

11931

M53.0

ICD-10 Finland

Cervicocranial syndrome

2.8

73.9

529

2016

I10

ICD-10 Finland

Essential (primary) hypertension

1.6

73.9

3858

30435

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.9

73.9

1351

7927

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.6

73.7

2646

18998

Z50.1

ICD-10 Finland

Other physical therapy

3.2

73.4

419

1375

NA7BT

NOMESCO Finland

Injection to spinal facet joint with radiological guidance

725.5

73.3

R42

ICD-10 Finland

Dizziness and giddiness

1.8

72.0

1357

8033

SPAT1216

SPAT

Assessment of functional ability

2.0

71.1

1004

5344

G55.1

ICD-10 Finland

Nerve root and plexus compressions in intervertebral disc disorders

23.2

71.0

103

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.7

71.0

1901

12565

WX290

NOMESCO Finland

Other blockade of nerve

1.6

70.9

2825

20772

C07AB07

ATC

bisoprolol; oral

1.6

70.7

3031

22689

ABC30

NOMESCO Finland

Decompression of cervical nerve roots

355.7

70.7

R52.9

ICD-10 Finland

Pain, unspecified

2.5

70.7

581

2397

R01BA52

ATC

pseudoephedrine, combinations; oral

1.6

70.6

2165

14864

WX308

NOMESCO Finland

Sacral anesthesy

149.5

70.0

NAG67

NOMESCO Finland

Posterior interbody fusion of lumbar spine, more than 2 vertebrae

+∞

69.9

SPAT1212

SPAT

Extensive examination of musculoskeletal system

2.6

69.6

567

2324

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.5

69.5

614

2631

AA1AD

NOMESCO Finland

CT of head and brain

1.8

69.1

1492

9223

ZXA05

NOMESCO Finland

Left side

1.7

69.1

1713

11050

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.6

69.0

2772

20381

J02AC01

ATC

fluconazole; systemic

1.6

69.0

2720

19905

NBG15

NOMESCO Finland

Acromioplastia, arthroscopic

2.8

69.0

475

1765

AB5CT

NOMESCO Finland

Blockage of nerv root with CT guidance

+∞

68.8

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.6

68.8

3366

25953

S46.0

ICD-10 Finland

Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder

2.5

68.8

596

2529

M02AA10

ATC

ketoprofen; topical

1.9

68.8

1102

6150

R53

ICD-10 Finland

Malaise and fatigue

1.9

68.7

1266

7425

KMAK

NOMESCO Finland

1.5

68.6

3422

26502

ZZH31

NOMESCO Finland

Bone allograft, small pieces

10.8

68.2

134

126

9211

FHL

Exploration or removal of diskusprolapse

179.2

68.1

M46.9

ICD-10 Finland

Inflammatory spondylopathy, unspecified

145.4

68.0

G55.1*M51.9

ICD-10 Finland

Nerve root and plexus compressions in intervertebral disc disorders (M50-M51+)

94.7

68.0

N06AB04

ATC

citalopram; systemic

1.8

67.7

1434

8803

SPAT1229

SPAT

Assessment of need for aid

2.5

67.5

554

2280

TAB20

NOMESCO Finland

Epidural puncture

19.2

67.5

104

ABC99

NOMESCO Finland

Other decompressive operation on spinal cord or nerve root

664.2

67.1

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

2.1

66.8

820

4108

X58

ICD-10 Finland

Exposure to other specified factors

2.0

66.3

893

4649

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.2

66.2

765

3732

Z01.2

ICD-10 Finland

Dental examination

1.6

65.9

2698

19863

G54.0

ICD-10 Finland

Brachial plexus disorders

6.3

65.4

180

291

C03CA01

ATC

furosemide; systemic

1.7

65.1

1634

10552

P01BA02

ATC

hydroxychloroquine; oral

2.3

64.9

629

2824

G55.2

ICD-10 Finland

Nerve root and plexus compressions in spondylosis

32.2

64.9

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

1.8

64.9

1350

8227

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.9

64.4

1136

6544

UKC02

NOMESCO Finland

Cystoscopy

2.0

64.4

936

5020

75618

ICD-8 Finland

Other congenital anomalies of musculoskeletal system, Maleformationes columnae vertebralis aliae

27.3

64.4

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

20.5

64.4

N05BA04

ATC

oxazepam; oral

1.7

64.1

1583

10164

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.5

64.0

523

2145

G99.2*M47.1

ICD-10 Finland

Spondylogenic compression of spinal cord

633.6

63.9

NA3CF

NOMESCO Finland

Lumbar spine extensive MRI examination with median intensity magnet

116.1

63.9

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.5

63.9

527

2175

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.6

63.8

2764

20576

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

2.1

63.3

782

3923

H02AB04

ATC

methylprednisolone; systemic

1.9

62.7

985

5436

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

2.9

62.7

418

1521

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

3.1

62.6

367

1226

M01AB08

ATC

etodolac; oral

2.5

61.9

530

2231

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.2

61.7

691

3320

R02

ICPC

Shortness of breath/dyspnoea

2.1

61.6

765

3845

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.7

61.2

435

1646

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.5

60.8

2758

20684

A06AD11

ATC

lactulose; oral

2.0

60.6

833

4364

R52.1

ICD-10 Finland

Chronic intractable pain

15.8

60.5

100

N05AH04

ATC

quetiapine; oral

1.9

60.5

1004

5650

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.2

60.5

663

3151

WX402

NOMESCO Finland

General anaesthesia

1.8

60.2

1152

6809

SPAT1249

SPAT

Treatment-related counselling outside office

1.5

60.1

2556

18865

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

3.7

59.8

272

748

SPAT1260

SPAT

Consultation of another employee

1.8

59.8

1176

7016

L12

ICPC

Hand/finger symptom/complaint

1.9

59.7

917

5013

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

5.2

59.7

192

376

WX725

NOMESCO Finland

Noninvasive ventilation

3.0

59.7

367

1266

N05CF02

ATC

zolpidem; oral

1.8

59.6

1190

7133

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.8

59.6

1216

7341

N04BC05

ATC

pramipexole; oral

2.5

59.6

514

2170

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

2.1

59.0

743

3755

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.6

58.8

1767

11941

E66.01

ICD-10 Finland

Obesity due to excess calories

2.4

58.6

522

2240

R05FA02

ATC

opium derivatives and expectorants; systemic

1.5

58.4

2707

20346

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.6

58.3

467

1894

N06AA10

ATC

nortriptyline; systemic

5.2

58.2

188

370

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

2.5

57.8

498

2102

R03DC03

ATC

montelukast; oral

1.8

57.6

1038

6005

RF210

NOMESCO Finland

4.0

57.4

240

613

7225B

ICD-9 Finland

Intervertebral disk disorders, Degeneration of thoracic or lumbar intervertebral disk[DEGEN DISCI INTERVERT THORAC SEU LUMBOSACR CUM INST]

+∞

57.4

9212

FHL

Other posterior root decompression surgery (eg laminectomy, Gill)

294.2

57.3

-1

NOMESCO Finland

1.6

57.2

2101

14930

A07EC01

ATC

sulfasalazine; oral, rectal

2.4

57.1

531

2331

M51.2

ICD-10 Finland

Other specified intervertebral disc displacement

36.8

56.9

M46.1

ICD-10 Finland

Sacroiliitis, not elsewhere classified

30.7

56.8

R05FB02

ATC

cough suppressants and expectorants

1.5

56.4

2513

18674

J01FA09

ATC

clarithromycin; systemic

1.6

56.2

2090

14884

M01AC01

ATC

piroxicam; systemic, rectal

1.9

56.0

908

5056

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

2.2

55.7

595

2793

L16

ICPC

Ankle symptom/complaint

2.1

55.1

653

3210

R60.0

ICD-10 Finland

Localized oedema

2.1

54.8

709

3617

NFB30

NOMESCO Finland

Primary total prosthetic replacement of hip joint not using cement

2.5

54.4

475

2016

ABD32

NOMESCO Finland

Implantation of temporary spinal stimulation device

21.0

54.3

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

5.4

54.3

168

315

72880

ICD-8 Finland

Vertebrogenic pain syndrome, Radicula syndrome of lower limbs

+∞

54.2

72510

ICD-8 Finland

Displacement of intervertebral disk, Lumbalis cum prolapsu disci

+∞

54.2

R03BA02

ATC

budesonide; inhalant

1.8

54.1

1117

6747

G04BD12

ATC

mirabegron; oral

2.1

53.9

662

3302

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

2.0

53.8

806

4357

ABC60

NOMESCO Finland

Decompression of cervical spinal cord

273.0

53.2

7231A

ICD-9 Finland

Other disorders of cervical region, Cervicalgia

+∞

53.2

SPAT1203

SPAT

Injection therapy, other than intramuscular or subcutaneous

3.1

53.2

310

1030

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

4.7

53.0

188

410

XX9AW

NOMESCO Finland

Production of copy from X-ray picture

3.6

52.9

254

730

J01EA01

ATC

trimethoprim; systemic

1.6

52.9

1596

10748

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.6

52.9

1580

10612

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.6

52.5

1673

11424

ABC66

NOMESCO Finland

Decompression of lumbal spinal channel

+∞

52.1

A03FA02

ATC

cisapride; oral, rectal

2.3

51.9

510

2298

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.7

51.8

1410

9230

Z71.8

ICD-10 Finland

Other specified counselling

1.6

51.4

1465

9707

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.6

51.4

389

1525

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

2.1

51.2

605

2965

K07.60

ICD-10 Finland

Snapping jaw

2.9

51.2

322

1126

72870

ICD-8 Finland

Vertebrogenic pain syndrome, Lumbalgia

+∞

51.1

M99.6

ICD-10 Finland

Osseous and subluxation stenosis of intervertebral foramina

73.2

51.0

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.9

50.9

848

4758

R01AD08

ATC

fluticasone; nasal

1.6

50.7

1826

12832

M01AH03

ATC

valdecoxib; oral

2.5

50.6

434

1824

WZA00

NOMESCO Finland

Short statement of of health and health related matters

2.5

50.4

418

1727

A28

ICPC

Limited function/disability NOS

1.9

50.4

855

4830

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

2.0

50.4

709

3736

A02BC04

ATC

rabeprazole; oral

2.2

49.9

564

2710

R05

ICPC

Cough

1.6

49.6

1394

9191

M15.0

ICD-10 Finland

Primary generalized (osteo)arthrosis

3.7

49.5

228

634

R07.3

ICD-10 Finland

Other chest pain

2.2

49.5

564

2723

M35.7

ICD-10 Finland

Hypermobility syndrome

8.9

49.0

106

120

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.8

48.9

957

5669

EBA00

NOMESCO Finland

Extraction of tooth

1.5

48.9

2022

14658

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

2.4

48.7

450

1964

R06AX27

ATC

desloratadine; oral

1.6

48.7

1682

11683

SDA02

NOMESCO Finland

Parodonthologic therapy

1.5

48.5

2090

15286

R03BA01

ATC

beclometasone; inhalant

1.8

48.0

903

5277

XKD00

NOMESCO Finland

Uroflowmetry

1.9

47.7

823

4669

M16.9

ICD-10 Finland

Coxarthrosis, unspecified

2.7

47.3

344

1318

M54.0

ICD-10 Finland

Panniculitis affecting regions of neck and back

9.3

47.2

100

109

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.9

47.2

816

4633

E66.8

ICD-10 Finland

Other obesity

2.6

47.2

357

1399

G56.2

ICD-10 Finland

Lesion of ulnar nerve

3.6

47.1

223

634

NF1BA

NOMESCO Finland

Hip extensive X-ray examination

3.4

46.9

241

731

G04CA02

ATC

tamsulosin; oral

1.7

46.9

1039

6390

NE1CG

NOMESCO Finland

Pelvic, hip and femur extensive MRI examination with high intensity magnet

4.7

46.5

163

352

M41.8

ICD-10 Finland

Other forms of scoliosis

25.2

46.2

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.2

46.2

517

2471

L29

ICPC

Musculoskeletal sympt/complt other

2.2

45.6

479

2224

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.1

45.4

539

2645

K30

ICD-10 Finland

Functional dyspepsia

2.0

45.3

652

3456

M13.9

ICD-10 Finland

Arthritis, unspecified

2.3

45.3

462

2115

N06AB03

ATC

fluoxetine; oral

1.8

45.3

809

4640

D07AC01

ATC

betamethasone; topical

1.5

45.3

2148

15991

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.5

45.2

2108

15633

R05

ICD-10 Finland

Cough

1.7

45.1

1193

7713

C07AA05

ATC

propranolol; systemic

1.6

44.9

1208

7846

XX2CT

NOMESCO Finland

Other injection with CT guidance

+∞

44.8

7245A

ICD-9 Finland

Other and unspecified disorders of back, Backache, unspecified

+∞

44.8

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.9

44.8

736

4101

L04AA13

ATC

leflunomide; oral

3.6

44.7

211

599

H04.10

ICD-10 Finland

Dry eye syndrome

2.0

44.7

623

3262

R03BA05

ATC

fluticasone; inhalant

1.7

44.6

1113

7074

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.2

44.6

496

2363

R5140

NOMESCO Finland

Monitoring the use of the aid

1.9

44.6

670

3614

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

2.5

44.4

357

1448

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.6

44.2

340

1346

N05CD07

ATC

temazepam; oral

1.9

43.8

758

4297

A02BA04

ATC

nizatidine; systemic

2.2

43.7

488

2331

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

2.3

43.7

449

2065

L01BA01

ATC

methotrexate; systemic (folic acid analog.)

2.8

43.7

289

1045

R01AD12

ATC

fluticasone furoate; nasal

1.5

43.7

1808

13046

NG1DA

NOMESCO Finland

X-ray of knees

4.6

43.6

158

353

R03AC03

ATC

terbutaline; inhalant

1.8

43.6

880

5250

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.9

43.3

739

4169

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.8

43.3

818

4775

R35

ICD-10 Finland

Polyuria

2.4

43.1

375

1588

M76.8

ICD-10 Finland

Other enthesopathies of lower limb, excluding foot

6.6

43.1

114

176

NA1AD

NOMESCO Finland

Cervical spine CT examination

3.1

43.1

249

824

M77.1

ICD-10 Finland

Lateral epicondylitis

2.3

43.0

434

1978

P03

ICPC

Feeling depressed

2.1

43.0

495

2397

SPAT1312

SPAT

General health counselling

1.5

42.9

1945

14301

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

2.1

42.9

543

2735

SFA40

NOMESCO Finland

Replacement of krone of tooth

1.6

42.9

1387

9437

SPAT1254

SPAT

Administration of medicine

1.8

42.9

848

5024

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.3

42.8

422

1900

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.8

42.8

881

5286

R20.2

ICD-10 Finland

Paraesthesia of skin

2.4

42.7

386

1666

L14

ICPC

Leg/thigh symptom/complaint

2.2

42.6

468

2215

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.6

42.5

1222

8062

SFA00

NOMESCO Finland

Small filling

1.8

42.5

816

4787

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

2.2

42.5

477

2282

R96

ICPC

Asthma

2.0

42.4

548

2782

M19.1

ICD-10 Finland

Post-traumatic arthrosis of other joints

3.6

42.3

198

559

NF1DA

NOMESCO Finland

X-ray of hips

4.0

42.2

176

450

N06AB10

ATC

escitalopram; oral

1.6

42.1

1168

7632

R03AK07

ATC

formoterol and budesonide; inhalant

1.6

42.1

1187

7789

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.9

42.1

664

3642

M20.1

ICD-10 Finland

Hallux valgus (acquired)

2.0

41.9

588

3086

SPAT1240

SPAT

Therapeutic discussion

2.0

41.9

592

3116

WX320

NOMESCO Finland

Spinalanesthesy

1.6

41.5

1416

9748

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.1

41.3

494

2429

M01AB51

ATC

indometacin, combinations; oral, rectal

4.0

41.2

171

435

NA3DG

NOMESCO Finland

Lumbar spine very extensive MRI examination with high intensity magnet

16.6

41.0

E0000UV

ATC

1.4

40.9

2443

18955

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.5

40.8

1685

12115

7561A

ICD-9 Finland

Other congenital musculoskeletal anomalies, Anomalies of spine[SPONDYLOLISTHESIS CONGENITA]

110.7

40.7

SPAT1202

SPAT

Intra-articular injection

3.0

40.7

243

823

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

4.6

40.6

146

324

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.1

40.5

499

2484

M76.0

ICD-10 Finland

Gluteal tendinitis

5.9

40.4

116

200

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

1.9

40.3

595

3180

C01DA14

ATC

isosorbide mononitrate; oral

1.8

40.3

741

4284

N01

ICPC

Headache

2.0

40.3

536

2755

Z02.7

ICD-10 Finland

Issue of medical certificate

2.3

40.0

379

1672

NA3BM

NOMESCO Finland

Lumbar spine MRI examination with 3 Tesla magnet

44.8

40.0

RF120

NOMESCO Finland

6.8

39.9

103

154

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

1.9

39.9

684

3858

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.7

39.9

294

1133

NBL00

NOMESCO Finland

Suture or reinsertation of rotator cuff of shoulder

2.4

39.8

361

1561

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.3

39.6

371

1628

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.6

39.4

1190

7936

NHG80

NOMESCO Finland

Fusion of first tarsometatarsal joint

2.7

39.4

281

1064

C10AA05

ATC

atorvastatin; oral

1.4

39.4

2351

18204

L90

ICPC

Osteoarthrosis of knee

2.2

39.3

426

2004

J45

ICD-10 Finland

Asthma

1.9

39.3

604

3278

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

3.4

39.2

195

578

M43.9

ICD-10 Finland

Deforming dorsopathy, unspecified

389.5

39.1

SPAT1028

SPAT

Ultrasound examination of paranasal sinuses

2.3

39.1

371

1641

L88

ICPC

Rheumatoid/seropositive arthritis

2.8

38.8

266

985

SDA01

NOMESCO Finland

Simple parodonthologic therapy

1.5

38.3

1525

10853

R01AD01

ATC

beclometasone; nasal

1.7

38.3

974

6205

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.8

38.2

751

4432

G99.2*M50.0

ICD-10 Finland

Cervical disc disorder with myelopathy

379.4

38.1

G99.2*M47.9

ICD-10 Finland

Myelopathy in spondylosis

379.4

38.1

L11

ICPC

Wrist symptom/complaint

2.0

38.0

494

2513

C10AA07

ATC

rosuvastatin; oral

1.5

38.0

1515

10782

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.4

38.0

350

1526

SPAT1325

SPAT

Vaccination

1.4

37.8

2086

15881

J45.1

ICD-10 Finland

Nonallergic asthma

2.2

37.8

420

1999

D01

ICPC

Abdominal pain/cramps general

1.9

37.8

608

3355

ZXA10

NOMESCO Finland

Bilateral

1.6

37.6

1123

7461

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

3.3

37.5

198

614

7240B

ICD-9 Finland

Other and unspecified disorders of back, Spinal stenosis, other than cervical[STENOSIS CANALIS SPINALIS LUMBOSACRALIS]

+∞

37.5

R09

ICPC

Sinus symptom/complaint

2.1

37.4

454

2243

R74

ICPC

Upper respiratory infection acute

1.5

37.3

1605

11612

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

3.4

37.2

187

559

SPAT1097

SPAT

Recording of ECG

1.7

37.2

912

5745

NHU20

NOMESCO Finland

Removal of internal fixation device from ankle or foot

2.5

37.1

302

1233

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.7

37.1

838

5155

L85

ICPC

Acquired deformity of spine

24.9

37.0

SPAT1058

SPAT

PEF monitoring instruction

2.0

36.9

514

2685

N06AA12

ATC

doxepin; systemic

2.3

36.9

343

1503

M01AE52

ATC

naproxen and esomeprazole; oral

2.9

36.8

230

802

H02BX01

ATC

methylprednisolone, combinations; systemic

2.4

36.8

337

1465

N03AX09

ATC

lamotrigine; oral

2.6

36.8

279

1094

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.1

36.7

451

2241

M01AG02

ATC

tolfenamic acid; oral, rectal

1.6

36.6

968

6226

R13

ICD-10 Finland

Dysphagia

2.2

36.5

379

1746

M19.8

ICD-10 Finland

Other specified arthrosis

2.9

36.5

229

802

SCA01

NOMESCO Finland

Simple analysis and advice of nutrition with regard to dentistry

1.5

36.2

1627

11863

M20.4

ICD-10 Finland

Other hammer toe(s) (acquired)

2.5

36.2

297

1220

M50.8

ICD-10 Finland

Other cervical disc disorders

60.3

36.1

NAG60

NOMESCO Finland

Anterior fusion of lumbar spine with fixation

359.0

36.0

R51

ICD-10 Finland

Headache

2.5

35.9

297

1221

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.6

35.6

967

6263

NAG41

NOMESCO Finland

Anterior fusion of cervical spine with fixation

37.7

35.5

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.5

35.5

1545

11183

RF420

NOMESCO Finland

5.1

35.5

115

229

NAG99

NOMESCO Finland

Other excision, reconstruction or fusion of joints of spine, unspecified

+∞

35.4

F51.0

ICD-10 Finland

Nonorganic insomnia

1.7

35.4

729

4361

M41.5

ICD-10 Finland

Other secondary scoliosis

52.8

35.4

C07AB02

ATC

metoprolol; systemic

1.6

35.4

1156

7842

K59.09

ICD-10 Finland

Constipation, unspecified

2.3

35.3

341

1521

A01AB09

ATC

miconazole; local oral

1.9

35.3

528

2834

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.7

35.2

812

5022

XKC03

NOMESCO Finland

Water cystometry

3.0

34.8

213

734

M70.7

ICD-10 Finland

Other bursitis of hip

3.4

34.7

176

530

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.6

34.7

1040

6902

NB1BG

NOMESCO Finland

Shoulder and humerus MRI examination with high intensity magnet

4.0

34.5

142

360

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.1

34.4

394

1901

NA3CM

NOMESCO Finland

Lumbar spine extensive MRI examination with 3 Tesla magnet

32.3

34.3

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.7

34.2

753

4593

N30.0

ICD-10 Finland

Acute cystitis

1.7

34.2

792

4903

M48.1

ICD-10 Finland

Ankylosing hyperostosis [Forestier]

57.4

34.2

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

2.9

34.1

215

755

M09AX01

ATC

hyaluronic acid; parenteral

2.3

34.1

322

1421

D82

ICPC

Teeth/gum disease

1.4

34.0

2070

15985

M41.2

ICD-10 Finland

Other idiopathic scoliosis

42.2

34.0

M41.1

ICD-10 Finland

Juvenile idiopathic scoliosis

65.3

34.0

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

2.8

33.9

227

827

WX002

NOMESCO Finland

Sedation and analgesia

1.5

33.9

1213

8399

H02AB07

ATC

prednisone; oral

1.7

33.8

848

5368

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.4

33.7

308

1337

C08CA01

ATC

amlodipine; oral

1.4

33.7

2122

16477

M03BX01

ATC

baclofen; systemic

4.6

33.6

118

257

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.2

33.6

341

1557

M40.1

ICD-10 Finland

Other secondary kyphosis

+∞

33.3

G04BD08

ATC

solifenacin; oral

2.1

33.3

402

1981

J01CE02

ATC

phenoxymethylpenicillin; oral

1.4

33.2

4427

38872

M53.8

ICD-10 Finland

Other specified dorsopathies

13.3

33.1

XF402

NOMESCO Finland

ECG with work load test

1.8

33.1

667

3961

NGA30

NOMESCO Finland

Exploration of knee joint, arthroscopic

2.3

32.9

314

1392

SPAT1255

SPAT

Intravenous administration of medicine

2.1

32.9

401

1983

D19

ICPC

Teeth/gum symptom/complaint

1.5

32.9

1566

11520

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.6

32.9

952

6256

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

3.3

32.9

168

510

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

7.1

32.7

115

M76.6

ICD-10 Finland

Achilles tendinitis

2.8

32.5

215

779

Z00.0

ICD-10 Finland

General medical examination

1.6

32.5

1073

7286

H01

ICPC

Ear pain/earache

1.8

32.4

577

3293

NA3BG

SPAT

4.1

32.3

130

323

D07AB02

ATC

hydrocortisone butyrate; topical

1.4

32.2

1687

12634

B01AF01

ATC

rivaroxaban; oral

1.7

32.1

705

4293

U02

ICPC

Urinary frequency/urgency

1.7

32.0

778

4878

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.0

31.8

428

2205

N17

ICPC

Vertigo/dizziness

1.8

31.8

618

3625

WX720

NOMESCO Finland

Own respiration

2.5

31.7

251

1008

SHB00

NOMESCO Finland

Prepation and fitting of bite rail to mouth

1.9

31.7

510

2808

7561D

ICD-9 Finland

Other congenital musculoskeletal anomalies, Anomalies of spine[SPONDYLOLYSIS CONGENITA]

165.7

31.7

C10AA01

ATC

simvastatin; oral

1.4

31.6

2596

21045

WW502

NOMESCO Finland

Autotransfusion

7.6

31.6

100

A11

ICPC

Chest pain NOS

2.0

31.6

438

2283

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.0

31.5

452

2387

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.4

31.5

2919

24122

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.2

31.4

346

1641

G57.3

ICD-10 Finland

Lesion of lateral popliteal nerve

5.3

31.4

184

R10.2

ICD-10 Finland

Pelvic and perineal pain

3.7

31.3

140

382

M50.9

ICD-10 Finland

Cervical disc disorder, unspecified

17.6

31.3

SHA01

NOMESCO Finland

Correction of physiology of bite - simple therapy visit

1.8

31.3

613

3602

N06AX03

ATC

mianserin; oral

2.3

31.2

300

1335

S22.3

ICD-10 Finland

Fracture of rib

2.1

31.2

362

1756

RD211

NOMESCO Finland

2.3

31.2

307

1381

L03.0

ICD-10 Finland

Cellulitis of finger and toe

2.0

31.1

411

2101

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

2.2

31.0

334

1569

J01MA12

ATC

levofloxacin; systemic

1.5

31.0

1052

7183

R21

ICPC

Throat symptom/complaint

1.5

30.9

1033

7024

N06AB06

ATC

sertraline; oral

1.8

30.9

618

3659

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.6

30.8

869

5669

NAG53

NOMESCO Finland

Posterior or lateral fusion of thoracic spine with fixation, more than 3 vertebraea

110.5

30.7

M53.3

ICD-10 Finland

Sacrococcygeal disorders, not elsewhere classified

8.0

30.7

G57.1

ICD-10 Finland

Meralgia paraesthetica

4.8

30.6

104

219

G04BD04

ATC

oxybutynin; oral, transdermal

2.2

30.5

318

1470

SPAT1210

SPAT

Application of cast or individual aid

2.4

30.5

275

1186

M77.4

ICD-10 Finland

Metatarsalgia

2.2

30.4

320

1486

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.6

30.4

923

6130

205

Kela drug reimbursment

Chronic hypertension

1.4

30.4

1564

11657

SDA03

NOMESCO Finland

Demanding parodonthologic therapy

1.4

30.3

2265

18044

NAG42

NOMESCO Finland

Posterior fusion of cervical spine with or without fixation

38.2

30.2

P06

ICPC

Sleep disturbance

1.8

30.2

561

3240

M01AE11

ATC

tiaprofenic acid; oral, rectal

2.4

30.1

260

1097

R4120

NOMESCO Finland

Occupational therapy

2.0

30.0

379

1902

R03BB04

ATC

tiotropium bromide; inhalant

1.8

30.0

516

2907

UDH02

NOMESCO Finland

Rhinopharyngoscopy

2.0

29.9

386

1956

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

2.6

29.9

219

842

ZZH20

NOMESCO Finland

Graft of patients own bone

9.6

29.7

NA3AA

SPAT

3.5

29.7

142

410

T84.2

ICD-10 Finland

Mechanical complication of internal fixation device of other bones

25.7

29.6

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.8

29.6

533

3049

N03AF01

ATC

carbamazepine; oral, rectal

2.3

29.6

293

1322

F34.1

ICD-10 Finland

Dysthymia

2.7

29.6

213

812

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.6

29.5

744

4703

K59.0

ICD-10 Finland

Constipation

2.2

29.5

305

1403

SGB10

NOMESCO Finland

Fiiling of rooth of tooth with one root channel

1.7

29.4

705

4396

G54.4

ICD-10 Finland

Lumbosacral root disorders, not elsewhere classified

30.1

29.4

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.9

29.4

181

627

Z96.6

ICD-10 Finland

Presence of orthopaedic joint implants

2.4

29.3

250

1048

S06.0

ICD-10 Finland

Concussion

1.8

29.3

546

3157

J01CA08

ATC

pivmecillinam; oral

1.4

29.3

2471

20048

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

2.7

29.3

207

780

UJD02

NOMESCO Finland

Gastroscopy

2.3

29.2

290

1310

A98

ICPC

Health maint/preventive medicine

1.7

29.2

6859

65812

A07AA02

ATC

nystatin; oral

2.0

29.1

366

1832

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.4

29.1

263

1136

S15

ICPC

Foreign body in skin

2.0

29.1

368

1849

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

3.1

29.0

167

553

R1240

NOMESCO Finland

Social assessment of need and possibilities of rehabilitation

6.0

28.8

137

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

3.7

28.7

128

349

NA3BA

NOMESCO Finland

Lumbar spine extensive X-ray examination without contrast

25.1

28.7

W19

ICD-10 Finland

Unspecified fall

1.8

28.7

523

3001

G99.2

ICD-10 Finland

Myelopathy in diseases classified elsewhere

43.9

28.6

R55

ICD-10 Finland

Syncope and collapse

1.8

28.6

568

3352

NA1BA

NOMESCO Finland

Cervical spine extensive X-ray examination without contrast

7.0

28.5

102

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.7

28.4

624

3795

A46

ICD-10 Finland

Erysipelas

1.6

28.4

769

4956

NGF35

NOMESCO Finland

Plastic operation of joint cartilage of knee

2.5

28.3

231

946

J31.0

ICD-10 Finland

Chronic rhinitis

1.9

28.3

434

2350

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

5.9

28.2

137

72898

ICD-8 Finland

Vertebrogenic pain syndrome, Alia definita

+∞

28.1

NAW10

NOMESCO Finland

Reoperation for superficial infection in in surgery of spine or neck

+∞

28.1

K10.3

ICD-10 Finland

Alveolitis of jaws

2.4

28.1

244

1030

SGA02

NOMESCO Finland

Opening and dilatation of root canal of tooth

1.6

28.1

723

4597

RF220

NOMESCO Finland

4.1

27.9

112

279

M19.2

ICD-10 Finland

Other secondary arthrosis

4.5

27.9

101

228

S97

ICPC

Chronic ulcer skin

2.2

27.8

306

1447

R06AX22

ATC

ebastine; oral

1.5

27.8

1022

7089

P76

ICPC

Depressive disorder

2.1

27.7

322

1560

G99.2*M51.0

ICD-10 Finland

Lumbar and other intervertebral disc disorders with myelopathy

77.9

27.7

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.0

27.7

385

2005

R4110

SPAT

2.8

27.6

182

660

C05AA08

ATC

fluocortolone; rectal, topical

1.6

27.6

846

5624

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.4

27.4

1360

10033

NDG60

NOMESCO Finland

Arthroplasty of first CMC joint

3.9

27.4

116

303

RF410

NOMESCO Finland

4.5

27.3

219

1220

FHL

Arthroscopy

2.4

27.3

248

1075

A03CA02

ATC

clidinium and psycholeptics; oral

2.0

27.2

356

1811

R03BA08

ATC

ciclesonide; inhalant

1.8

27.1

488

2788

ABD99

NOMESCO Finland

Other operation on spinal cord or nerve for pain or impaired function

53.5

27.1

M99.3

ICD-10 Finland

Osseous stenosis of neural canal

53.5

27.1

M01AE51

ATC

ibuprofen, combinations; systemic

3.9

27.1

113

291

R33

ICD-10 Finland

Retention of urine

2.0

27.1

351

1781

7221A

ICD-9 Finland

Intervertebral disk disorders, Displacement of thoracic or lumbar intervertebral disk without myelopathy

+∞

27.1

G43.9

ICD-10 Finland

Migraine, unspecified

2.2

27.1

273

1242

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

2.1

27.0

315

1531

SPAT1106

SPAT

Acupuncture

7.0

27.0

M48

ICD-10 Finland

Other spondylopathies

26.5

27.0

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.7

27.0

660

4137

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.4

26.8

1988

15743

D06

ICPC

Abdominal pain localized other

1.8

26.7

448

2501

B01AC04

ATC

clopidogrel; oral

1.6

26.7

794

5236

S40.0

ICD-10 Finland

Contusion of shoulder and upper arm

2.4

26.7

227

952

G04CA01

ATC

alfuzosin; oral

1.7

26.6

531

3133

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.5

26.5

1185

8563

NBB20

NOMESCO Finland

Primary total prosthetic replacement of humero-scapular joint

4.4

26.4

222

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.6

26.4

199

781

M47.81

ICD-10 Finland

Other spondylosis, occipito-atlanto-axial region

14.7

26.4

K08.80

ICD-10 Finland

Toothache NOS

1.8

26.4

445

2489

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

4.1

26.4

104

255

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.4

26.4

1595

12196

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.3

26.3

253

1127

ACC53

NOMESCO Finland

Release of ulnar nerve

4.3

26.3

228

R03AC13

ATC

formoterol; inhalant

2.1

26.2

292

1391

SHA02

NOMESCO Finland

Correction of physiology of bite - basic therapy visit

2.0

26.2

359

1865

M48.8

ICD-10 Finland

Other specified spondylopathies

36.8

26.1

M01AB01

ATC

indometacin; systemic, rectal

1.9

26.1

389

2084

A02BX02

ATC

sucralfate; oral

2.4

26.1

235

1015

M43.3

ICD-10 Finland

Recurrent atlantoaxial subluxation with myelopathy

+∞

26.0

ABC50

NOMESCO Finland

Decopression of cervical spinal canal and nerve roots

+∞

26.0

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.3

26.0

2966

25038

M47

ICD-10 Finland

Spondylosis

7.1

26.0

L60.0

ICD-10 Finland

Ingrowing nail

2.3

25.9

239

1043

2309

FHL

Other measure in this category

40.2

25.8

Z98.1

ICD-10 Finland

Arthrodesis status

40.2

25.8

A04

ICPC

Weakness/tiredness general

1.6

25.7

663

4210

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.5

25.7

1022

7198

S29

ICPC

Skin symptom/complaint other

1.5

25.5

941

6522

R00.2

ICD-10 Finland

Palpitations

1.9

25.5

396

2152

NGB40

NOMESCO Finland

Primary total prosthetic replacement of knee joint with patellar part - sliding prosthesis

2.8

25.4

169

616

NH3FA

NOMESCO Finland

Weight-bearing X-ray of foot

3.2

25.4

135

424

R52.0

ICD-10 Finland

Acute pain

2.7

25.3

177

665

NJ3NA

NOMESCO Finland

Measurement of difference in extremity lengty with X-ray

3.3

25.3

129

393

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.6

25.3

680

4370

H57.1

ICD-10 Finland

Ocular pain

2.7

25.2

179

677

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.8

25.2

431

2419

C10AX09

ATC

ezetimibe; oral

1.7

25.2

618

3873

N06AX12

ATC

bupropion; oral

2.0

25.1

312

1556

N05BA12

ATC

alprazolam; oral

1.7

25.1

595

3694

J05AB01

ATC

aciclovir; systemic

1.4

25.1

1217

8927

TAD08

NOMESCO Finland

Sympathetic block on sacral Level

+∞

25.0

7213A

ICD-9 Finland

Spondylosis and allied disorders, Lumbosacral spondylosis without myelopathy

+∞

25.0

M75.2

ICD-10 Finland

Bicipital tendinitis

3.0

25.0

147

496

G83.4

ICD-10 Finland

Cauda equina syndrome

30.1

24.9

M15

ICD-10 Finland

Polyarthrosis

2.1

24.9

279

1334

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.4

24.9

212

890

M05BX04

ATC

denosumab; parenteral

2.1

24.9

301

1485

NBA30

NOMESCO Finland

Exploration of joint of shoulder or upper arm, arthroscopic

2.7

24.9

178

679

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.4

24.8

217

922

C08CA13

ATC

lercanidipine; oral

1.6

24.7

744

4918

M21.4

ICD-10 Finland

Flat foot [pes planus] (acquired)

2.6

24.7

185

725

RF421

NOMESCO Finland

7.8

24.6

R06.5

ICD-10 Finland

Mouth breathing

1.8

24.6

481

2821

AN1

Coronary angiography

1.7

24.6

599

3747

M09AA72

ATC

quinine, combinations with psycholeptics; systemic

2.8

24.5

160

577

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.1

24.4

270

1282

SDE02

NOMESCO Finland

Periodontal treatment by dental hygienist

1.4

24.4

1437

10915

L09

ICPC

Arm symptom/complaint

2.3

24.4

240

1083

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

2.2

24.4

252

1161

L18

ICPC

Muscle pain

2.4

24.3

211

893

NBG00

NOMESCO Finland

Plastic operation on acromioclavicular joint

3.7

24.3

107

290

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

2.0

24.3

321

1642

J46

ICD-10 Finland

Status asthmaticus

2.8

24.3

161

586

VALMI

NOMESCO Finland

1.4

24.2

1415

10731

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.5

24.2

192

776

SPAT1081

SPAT

Cardiorespiratory global assessment

2.0

24.2

331

1716

NDU20

NOMESCO Finland

Removal of internal fixation device from wrist or hand

2.9

24.2

151

529

2402

FHL

External neurolysis of the nerve and possible alteration of the pathway (nerve pressure)

3.5

24.2

113

322

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.4

24.1

1187

8723

SGC00

NOMESCO Finland

Local medication of root channels of tooth

1.6

24.1

596

3742

NB1CG

NOMESCO Finland

Shoulder and humerus extensive MRI examination with high intensity magnet

3.1

24.1

138

456

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

1.9

24.1

344

1812

Y83.1

ICD-10 Finland

Surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.9

24.0

100

259

M46.4

ICD-10 Finland

Discitis, unspecified

+∞

24.0

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

2.3

23.9

223

980

M02AA15

ATC

diclofenac; topical (antiinflammatory prep., non-steroids for topical use)

1.8

23.8

450

2612

C08CA05

ATC

nifedipine; systemic

2.0

23.8

332

1735

K03.64

ICD-10 Finland

Dental calculus supragingival

1.4

23.8

1618

12590

S80.0

ICD-10 Finland

Contusion of knee

1.9

23.8

354

1896

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.7

23.7

539

3306

J04AB02

ATC

rifampicin; systemic

4.5

23.7

191

M47.8

ICD-10 Finland

Other spondylosis

87.0

23.6

ZSN00

NOMESCO Finland

Procedure related to previous procedure classified in chapter N

6.9

23.6

N07BA03

ATC

varenicline; oral

2.0

23.5

298

1499

R11

ICD-10 Finland

Nausea and vomiting

1.8

23.5

409

2308

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.6

23.4

736

4913

D07AD01

ATC

clobetasol; topical

1.5

23.4

914

6404

WX306

NOMESCO Finland

Lumbar epidural anesthesy

2.0

23.4

308

1573

R1250

NOMESCO Finland

Evaluation of functional capability

3.0

23.4

136

455

M18.1

ICD-10 Finland

Other primary arthrosis of first carpometacarpal joint

3.2

23.4

126

400

M75.9

ICD-10 Finland

Shoulder lesion, unspecified

2.2

23.4

243

1123

D07AA02

ATC

hydrocortisone; topical

1.6

23.3

725

4830

SGA01

NOMESCO Finland

Tooth opening as first aid

1.5

23.2

856

5926

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.7

23.2

507

3074

C09CA06

ATC

candesartan; oral

1.4

23.2

1272

9529

K59.1

ICD-10 Finland

Functional diarrhoea

2.1

23.0

281

1394

J20

ICD-10 Finland

Acute bronchitis

1.7

23.0

533

3286

7227A

ICD-9 Finland

Intervertebral disk disorders, Intervertebral disk disorder with myelopathy[KAULANIKAMAN VÄLILEVYTYRÄ JUURIOIREINEEN]

+∞

22.9

G99.2*M47.0

ICD-10 Finland

Anterior spinal and vertebral artery compression syndromes

+∞

22.9

72899

ICD-8 Finland

Vertebrogenic pain syndrome, Other and unspecified

+∞

22.9

ABA99

NOMESCO Finland

Other diagnostic operation on spinal cord or nerve root

+∞

22.9

I20.09

ICD-10 Finland

Unstable angina

2.1

22.9

270

1318

SPAT1360

SPAT

Extensive global examination

1.8

22.8

423

2440

T82

ICPC

Obesity

2.3

22.8

208

905

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.4

22.8

1333

10098

NFC20

NOMESCO Finland

Secondary implantation of hip prosthesis

3.6

22.8

103

286

78559

ICD-8 Finland

Symptoms referable to abdomen and lower gastro-intestinal tract, Colica abdominalis NUD

2.3

22.7

207

900

ND2BA

NOMESCO Finland

Hand and fingers extensive X-ray examination

2.9

22.7

144

511

R15

ICD-10 Finland

Faecal incontinence

2.7

22.6

155

574

J01FA15

ATC

telithromycin; oral

1.6

22.6

600

3837

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.2

22.6

228

1041

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.5

22.6

898

6315

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

2.8

22.5

151

554

R10.0

ICD-10 Finland

Acute abdomen

2.5

22.4

174

696

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

3.5

22.4

107

311

WX702

NOMESCO Finland

Supraglottic ventilation device

1.9

22.3

322

1704

NBG10

NOMESCO Finland

Acromioplastia

2.7

22.3

153

568

M25.2

ICD-10 Finland

Flail joint

4.4

22.3

185

L04

ICPC

Chest symptom/complaint

1.9

22.2

315

1655

M18.0

ICD-10 Finland

Primary arthrosis of first carpometacarpal joints, bilateral

3.6

22.2

103

293

AEA50

NOMESCO Finland

Adjustment of implanted neurostimulator

11.4

22.1

R75

ICPC

Sinusitis acute/chronic

2.1

22.1

251

1208

M77.0

ICD-10 Finland

Medial epicondylitis

2.9

21.9

138

487

NHG77

NOMESCO Finland

Arthroplasty of interphalangeal tarsal joint(s)

2.7

21.9

155

587

M06.0

ICD-10 Finland

Seronegative rheumatoid arthritis

2.4

21.9

183

761

7233A

ICD-9 Finland

Other disorders of cervical region, Cervicobrachial syndrome (diffuse)

+∞

21.9

7225A

ICD-9 Finland

Intervertebral disk disorders, Degeneration of thoracic or lumbar intervertebral disk[DEGENERATIO DISCI INTERVERTEBRALIS THORAC SEU LUMB]

+∞

21.9

M46.3

ICD-10 Finland

Infection of intervertebral disc (pyogenic)

+∞

21.9

7242A

ICD-9 Finland

Other and unspecified disorders of back, Lumbago

+∞

21.9

P01

ICPC

Feeling anxious/nervous/tense

1.7

21.9

449

2672

WX111

NOMESCO Finland

Local infiltration anesthesia

2.3

21.9

206

910

E000001

ATC

1.4

21.8

1139

8445

A03

ICPC

Fever

1.5

21.8

789

5434

WYA10

NOMESCO Finland

First aid or other corresponding healthcare contact

1.7

21.7

429

2525

L89

ICPC

Osteoarthrosis of hip

2.3

21.7

205

907

TQW40

SPAT

2.3

21.7

196

847

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.7

21.6

491

3011

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.6

21.6

617

4019

M75.8

ICD-10 Finland

Other shoulder lesions

2.4

21.6

179

743

S21

ICPC

Skin texture symptom/complaint

1.5

21.6

684

4573

NBL22

NOMESCO Finland

Myotomy, tenotomy or excision of tendon of upper arm

3.5

21.5

103

300

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

2.9

21.5

132

459

K29.7

ICD-10 Finland

Gastritis, unspecified

2.3

21.5

198

865

WX204

NOMESCO Finland

Axillary plexus blockaced

2.3

21.5

195

845

N81.6

ICD-10 Finland

Rectocele

1.8

21.5

409

2378

M79.9

ICD-10 Finland

Soft tissue disorder, unspecified

5.6

21.5

114

NG1BG

NOMESCO Finland

Knee and lower leg MRI examination with high intensity magnet

2.3

21.4

206

919

R60.9

ICD-10 Finland

Oedema, unspecified

2.1

21.4

257

1264

L99

ICPC

Musculoskeletal disease other

3.0

21.4

125

421

50099

ICD-8 Finland

Hypertrophy of tonsils and adenoids

1.6

21.4

622

4071

WX200

NOMESCO Finland

Interscalenous plexus blockade

3.0

21.4

126

427

NHG76

NOMESCO Finland

Arthroplasty of other tarsometatarsal joint

3.2

21.3

116

372

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

2.9

21.3

129

444

NA2AD

NOMESCO Finland

Thoracic spine CT examination

8.6

21.3

R12

ICD-10 Finland

Heartburn

1.8

21.3

380

2166

SPAT1283

SPAT

Restricted health certificate

1.5

21.2

837

5872

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

2.5

21.2

166

667

JDF11

NOMESCO Finland

Laparoscopic gastric bypass

3.5

21.2

100

288

NHL16

NOMESCO Finland

Tenolysis or tenosynovectomy of achilles tendon

14.6

21.1

J45.8

ICD-10 Finland

Mixed asthma

2.5

21.1

166

670

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.7

21.0

448

2695

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

2.0

21.0

265

1333

J01DA06

ATC

[U] cefuroxime; systemic

1.5

20.9

822

5762

7385A

ICD-9 Finland

Other acquired deformity of back or spine

60.2

20.9

D20

ICPC

Mouth/tongue/lip symptom/complaint

2.1

20.8

239

1153

M04AA01

ATC

allopurinol; systemic

1.6

20.8

607

3974

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.5

20.8

736

5044

M22.4

ICD-10 Finland

Chondromalacia patellae

2.5

20.7

169

694

R03AC12

ATC

salmeterol; inhalant

2.1

20.7

231

1103

R06AX13

ATC

loratadine; oral

1.5

20.7

848

5998

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

2.2

20.7

219

1023

K29.3

ICD-10 Finland

Chronic superficial gastritis

2.4

20.6

182

780

SPAT1211

SPAT

Application of soft bandage

1.7

20.6

489

3034

L20

ICPC

Joint symptom/complaint NOS

2.3

20.6

198

884

M72.2

ICD-10 Finland

Plantar fascial fibromatosis

1.7

20.6

403

2365

L04AB01

ATC

etanercept; parenteral

3.7

20.6

249

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.7

20.6

430

2571

M43

ICD-10 Finland

Other deforming dorsopathies

110.3

20.6

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.8

20.5

376

2162

G57.6

ICD-10 Finland

Lesion of plantar nerve

2.8

20.5

132

474

SPAT1262

SPAT

Handing over of treatment supplies

1.4

20.5

998

7300

M75.0

ICD-10 Finland

Adhesive capsulitis of shoulder

1.9

20.5

299

1587

TAC00

NOMESCO Finland

Peripheral nerve block

9.0

20.5

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

2.9

20.5

129

455

L83

ICPC

Neck syndrome

5.9

20.5

NA2CG

NOMESCO Finland

Thoracal spine extensive MRI examination with high intensity magnet

5.9

20.5

D11

ICPC

Diarrhoea

1.6

20.4

549

3523

S83.2

ICD-10 Finland

Tear of meniscus, current

1.8

20.4

387

2249

J02AC02

ATC

itraconazole; systemic

1.4

20.4

1062

7863

D07AC13

ATC

mometasone; topical

1.3

20.4

1661

13244

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.4

20.3

1036

7639

AEA00

NOMESCO Finland

Replacement of impulse generator of stimulation device in the nervous system

12.5

20.3

N39.3

ICD-10 Finland

Stress incontinence

1.7

20.1

419

2503

NAW00

NOMESCO Finland

Repair of wound dehiscence in surgery of spine or neck

48.1

20.1

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.3

20.1

180

777

M19.9

ICD-10 Finland

Arthrosis, unspecified

2.2

20.0

207

957

R50.9

ICD-10 Finland

Fever, unspecified

1.5

20.0

692

4718

R06AE09

ATC

levocetirizine; oral

1.5

20.0

817

5769

M05.9

ICD-10 Finland

Seropositive rheumatoid arthritis, unspecified

2.6

19.9

145

561

SPAT1284

SPAT

Extensive health certificate

2.5

19.9

152

604

P25

ICPC

Phase of life problem adult

2.2

19.9

204

940

U05

ICPC

Urination problems other

2.1

19.9

235

1151

R25.2

ICD-10 Finland

Cramp and spasm

2.9

19.9

123

431

TNX32

NOMESCO Finland

Custom moulded splint, unspecified region

1.9

19.9

282

1482

-50

ICPC

Medication/prescr/renewal

2.1

19.9

232

1128

R39.1

ICD-10 Finland

Other difficulties with micturition

2.5

19.8

154

617

A05

ICPC

Feeling ill

2.0

19.8

274

1429

N62

ICD-10 Finland

Hypertrophy of breast

2.1

19.8

232

1132

N41.1

ICD-10 Finland

Chronic prostatitis

3.0

19.8

114

380

7228C

ICD-9 Finland

Intervertebral disk disorders, Postlaminectomy syndrome[SYNDROMA LUMBOSACRALE POSTLAMINECTOMIAM]

+∞

19.8

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.6

19.8

525

3357

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

1.7

19.8

461

2849

SPAT1252

SPAT

Overall medication plan or its review

1.8

19.7

368

2126

M65.3

ICD-10 Finland

Trigger finger

2.0

19.7

249

1253

WX610

NOMESCO Finland

Patient controlled analgesia

5.5

19.7

106

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

2.0

19.7

255

1295

C09CA01

ATC

losartan; oral

1.4

19.6

1379

10736

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.3

19.6

177

768

NAT20

NOMESCO Finland

Reinsertion and tuning of internal fixation device

200.5

19.6

R30.0

ICD-10 Finland

Dysuria

2.2

19.5

193

874

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.7

19.4

401

2392

NG1AE

NOMESCO Finland

Knee joint ultrasound exmination

3.8

19.4

216

TNX50

NOMESCO Finland

Removal of cutom molded cast and internal stretch

1.9

19.4

287

1535

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

3.1

19.4

106

342

C10AA03

ATC

pravastatin; oral

1.7

19.4

376

2201

N06AX26

ATC

vortioxetine; oral

1.9

19.4

276

1454

J01FA01

ATC

erythromycin; systemic

1.5

19.4

741

5160

H03AA01

ATC

levothyroxine sodium; systemic

1.3

19.3

1413

11067

T84.5

ICD-10 Finland

Infection and inflammatory reaction due to internal joint prosthesis

3.5

19.3

263

K03.00

ICD-10 Finland

Approximal wear

1.9

19.3

278

1473

G04BD07

ATC

tolterodine; oral

1.9

19.3

269

1406

K05.30

ICD-10 Finland

Periodontitis complex

1.5

19.3

716

4957

XQ800

NOMESCO Finland

Prick test

1.7

19.2

397

2369

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.3

19.2

1521

12061

G25.8

ICD-10 Finland

Other specified extrapyramidal and movement disorders

2.6

19.2

143

561

XKD06

NOMESCO Finland

Physiologic investigation of micturition

2.5

19.2

153

623

JN3AD

NOMESCO Finland

Abdominal CT examination

1.7

19.1

405

2434

NBF25

NOMESCO Finland

Operation for humeroscapular osteochondritis, arthroscopic

2.7

19.1

130

481

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

2.6

19.1

139

537

M67.4

ICD-10 Finland

Ganglion

1.8

19.1

350

2013

A29

ICPC

General symptom/complaint other

1.6

19.0

587

3895

NGF00

NOMESCO Finland

Excision of plica of synovy of knee

2.7

19.0

135

515

L95

ICPC

Osteoporosis

2.2

19.0

189

856

AEA24

NOMESCO Finland

Removal of spinal stimulation elecrode

12.2

19.0

RF313

NOMESCO Finland

12.2

19.0

XG410

NOMESCO Finland

Flow-volume spirometry

2.1

18.9

216

1043

TDM10

NOMESCO Finland

Puncture of maxillary antrum

2.1

18.9

206

974

SPF00

NOMESCO Finland

Repatation of teeth prosthesis

2.4

18.9

160

670

R01AD05

ATC

budesonide; nasal

1.7

18.8

435

2677

M51

ICD-10 Finland

Other intervertebral disc disorders

10.6

18.8

C01CA24

ATC

epinephrine; parenteral

1.8

18.8

322

1812

ICD-10 Finland

2.6

18.8

136

524

7210A

ICD-9 Finland

Spondylosis and allied disorders, Cervical spondylosis without myelopathy

+∞

18.8

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.7

18.7

375

2219

M75.5

ICD-10 Finland

Bursitis of shoulder

2.8

18.7

119

425

D12

ICPC

Constipation

2.3

18.6

171

748

B01AX06

ATC

[U] rivaroxaban; oral

2.6

18.6

140

552

M89.0

ICD-10 Finland

Algoneurodystrophy

5.7

18.6

J01DA08

ATC

[U] cefaclor; oral

1.6

18.6

534

3482

H53.1

ICD-10 Finland

Subjective visual disturbances

1.8

18.6

324

1834

M53.9

ICD-10 Finland

Dorsopathy, unspecified

9.3

18.5

NB1AD

NOMESCO Finland

Shoulder CT examination

3.1

18.5

103

337

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

1.7

18.5

385

2301

NA7BG

NOMESCO Finland

Spine and spinal cord MRI examination with high intensity magnet

8.4

18.4

N06AB05

ATC

paroxetine; oral

1.8

18.3

338

1948

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.4

18.3

1107

8404

U01

ICPC

Dysuria/painful urination

1.7

18.3

386

2317

K07

ICPC

Swollen ankles/oedema

2.0

18.2

222

1100

SPAT1285

SPAT

Provision of consultation response

1.9

18.2

285

1556

JBC01

NOMESCO Finland

Laparoscopic gastro-oesophageal antireflux operation

2.8

18.2

120

437

S01GX01

ATC

cromoglicic acid; ophthalmic

1.4

18.2

1105

8392

N31.2

ICD-10 Finland

Flaccid neuropathic bladder, not elsewhere classified

4.5

18.1

143

TQW40

NOMESCO Finland

Remowal of suture of skin

1.7

18.1

403

2458

C03AA03

ATC

hydrochlorothiazide; oral

1.6

18.1

528

3460

SXA20

NOMESCO Finland

Local application of medicine to mouth

1.9

18.0

283

1547

M05BA07

ATC

risedronic acid; oral

2.2

18.0

190

887

M01AB16

ATC

aceclofenac; oral

2.2

18.0

188

876

M17.3

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3013707) Erythrocyte sedimentation rate by Westergren method

6532

48420

2.71

289.68

5.2

3.7

mm/h

11.8

12.5

3.68

6172

44491

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

4670

30004

2.29

284.82

4.5

3.8

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

5277

37617

2.13

222.81

4.9

4.5

mmol/l

6.5

6.7

10.49

5000

35067

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

2014

10159

2.30

206.75

1.3

1.2

iu/ml

34.8

39.3

0.43

619

3288

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1917

9591

2.30

199.77

1.3

1.2

u/ml

10.7

16.0

2.22

750

3679

(3031040) Bacteria [#/volume] in Urine by Automated count

5640

42155

2.08

197.23

5.5

4.0

e6/l

1919.2

1695.3

0.10

586

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

3016

18443

2.00

183.61

2.4

2.0

u/l

183.7

224.0

1.63

2839

17193

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

6409

51316

2.13

171.48

7.9

7.4

u/l

75.1

79.1

13.38

6119

48137

(3037467) Urinalysis macro (dipstick) panel - Urine

5777

44578

2.00

171.01

5.3

4.0

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

4160

29180

1.86

160.64

6.2

5.9

mmol/l

1.2

4.41

3814

26279

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

4496

32375

1.86

159.01

7.2

6.6

mmol/l

1.2

2.62

3889

27083

(3032080) INR in Blood by Coagulation assay

3730

25840

1.81

144.76

7.7

8.4

inr

1.2

7.80

1024

7388

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

2985

19448

1.84

140.70

2.7

2.5

u/l

56.2

59.5

1.84

2789

17843

(3019150) Specific gravity of Urine by Refractometry

2167

12857

1.93

135.98

5.1

3.7

kg/l

1.0

0.72

297

2024

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

7628

67464

2.84

134.62

17.9

12.7

mg/l

22.6

24.3

4.29

6416

52271

(3044640) Blood type and Crossmatch panel - Blood

3070

20380

1.81

134.56

2.4

2.3

—

(3001604) Monocytes [#/volume] in Blood

4325

31933

1.75

129.50

6.5

5.7

e9/l

0.6

0.07

3841

27270

(3006315) Basophils [#/volume] in Blood

4338

32068

1.75

129.22

6.6

5.7

e9/l

0.0

2.55

3851

27382

(3013115) Eosinophils [#/volume] in Blood

4454

33177

1.75

129.08

6.7

5.9

e9/l

0.2

1.86

4011

28802

(3019198) Lymphocytes [#/volume] in Blood

4413

32866

1.74

127.20

6.6

5.7

e9/l

1.9

0.03

3972

28600

(3024561) Albumin [Mass/volume] in Serum or Plasma

3875

28032

1.72

122.23

4.9

4.8

g/l

35.8

35.4

3.05

3613

25969

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

6254

51831

1.87

121.47

4.5

3.9

pmol/l

14.8

0.73

5769

47056

(3035350) Ketones [Presence] in Urine by Test strip

4195

31199

1.70

117.95

4.4

3.3

estimate

0.0

1.08

738

5639

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

4488

34000

1.71

117.72

5.6

6.5

umol/l

10.3

11.5

9.09

4245

32263

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1323

6915

2.09

116.93

6.1

7.6

kpa

5.1

0.58

1274

6615

(3009261) Glucose [Presence] in Urine by Test strip

4245

31724

1.70

116.76

4.4

3.4

estimate

0.0

0.01

744

5607

(3027801) Oxygen [Partial pressure] in Arterial blood

1321

6912

2.09

116.37

6.1

7.6

kpa

12.8

12.7

0.40

1273

6609

(3019060) Gas panel - Arterial blood

856

3775

2.42

114.36

4.7

5.1

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

832

3630

2.44

113.80

7.0

7.3

mmol/l

24.6

24.5

0.41

781

3380

(3021601) Nitrite [Presence] in Urine by Test strip

4196

31424

1.69

113.08

5.6

4.6

estimate

0.0

0.18

766

5727

(3003396) Base excess in Arterial blood by calculation

1308

6929

2.06

111.00

6.1

7.6

mmol/l

1.3

1.0

1.83

1016

5482

(3019550) Sodium [Moles/volume] in Serum or Plasma

7790

70697

2.99

110.84

19.9

14.7

mmol/l

139.5

139.7

11.51

7698

68751

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

2396

15488

1.77

109.97

2.3

—

(3016502) Oxygen saturation in Arterial blood

1194

6135

2.11

109.90

6.2

8.1

96.4

95.8

4.15

1153

5910

(3013650) Neutrophils [#/volume] in Blood by Automated count

4825

37644

1.68

109.90

9.0

9.5

e9/l

4.1

4.0

2.46

4321

32600

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

3334

23686

1.69

108.19

4.0

3.1

ng/l

54.6

67.9

0.23

2271

15841

(3023103) Potassium [Moles/volume] in Serum or Plasma

7796

70937

2.96

107.31

19.9

14.9

mmol/l

4.0

3.72

7693

68839

(3001122) Ferritin [Mass/volume] in Serum or Plasma

3671

26800

1.67

106.94

3.1

2.7

ug/l

114.6

136.3

5.47

3405

24788

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1124

5725

2.12

105.58

6.6

8.5

g/l

120.7

120.5

0.10

1084

5510

(3026493) Urate [Moles/volume] in Serum or Plasma

2511

16727

1.72

102.09

2.6

2.5

umol/l

2366.0

4469.4

2.52

2176

14543

(3042936) Bacteria identified in Isolate by Culture

1498

8575

1.91

100.80

2.3

2.0

—

(3029937) Albumin [Presence] in Urine by Test strip

2452

16328

1.72

99.26

5.1

3.7

estimate

0.0

2.80

745

5537

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

2295

15047

1.73

98.08

2.5

2.2

mg/l

2.9

3.0

1.42

2000

12784

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

7086

62434

1.99

97.59

5.5

4.6

mu/l

1.8

2.2

4.57

6638

56905

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

2085

13383

1.75

95.73

1.8

1.7

mg/l

1.1

1.3

1.13

1628

10252

(3044889) 12 lead EKG panel

5750

47794

1.68

95.14

4.4

3.5

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

3667

27307

1.62

94.84

2.5

2.2

nmol/l

79.4

78.0

2.22

3356

24473

(3011397) Hemoglobin [Presence] in Urine by Test strip

2188

14298

1.72

93.91

4.7

3.3

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

3564

26416

1.62

93.55

2.2

1.9

pmol/l

98.3

96.5

1.22

1813

13346

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

7128

63262

1.96

91.16

6.3

5.5

mmol/mol

39.5

39.7

0.67

6719

58255

(3026008) Bacteria identified in Urine by Culture

2708

19081

1.63

85.32

3.6

2.9

—

(3037522) Nuclear Ab [Titer] in Serum

1387

8149

1.84

84.56

1.4

1.3

titre

590.4

543.9

0.36

300

1795

(3018418) pH of Serum or Plasma

2703

19097

1.62

83.90

4.2

4.1

7.4

0.03

468

3739

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

2531

17650

1.63

82.57

3.1

2.8

ng/l

1011.5

1380.4

6.63

2159

15092

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

3246

24065

1.58

81.60

4.7

3.5

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1549

9528

1.77

80.66

2.0

1.8

—

(3023368) Bacteria identified in Blood by Culture

2409

16673

1.63

80.63

4.3

4.2

—

(40761511) CBC panel - Blood by Automated count

7713

71096

2.40

79.94

16.9

12.1

—

(3007853) Bacteria identified in Skin by Aerobe culture

1216

7048

1.85

76.79

1.9

1.7

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

7369

66935

1.98

76.44

5.1

4.4

mmol/l

5.9

0.46

6870

60870

(3006504) Eosinophils/100 leukocytes in Blood

3891

30407

1.53

75.07

6.8

5.9

2.9

2.8

1.94

3637

28237

(40761535) Cells panel - Urine sediment

883

4653

2.01

74.07

4.1

3.2

—

(40768797) Stomach Pathology biopsy report

1423

8745

1.76

73.62

1.2

—

(3019069) Monocytes/100 leukocytes in Blood

3900

30579

1.52

73.50

7.1

6.2

8.5

8.6

2.64

3661

28553

(3039000) Anion gap in Blood

369

1331

2.86

73.47

5.9

7.4

mmol/l

10.9

11.4

1.54

342

1190

(3018572) Chloride [Moles/volume] in Blood

369

1332

2.85

73.37

5.9

7.4

mmol/l

105.1

105.2

0.16

342

1191

(3047181) Lactate [Moles/volume] in Blood

459

1866

2.55

72.20

5.6

6.3

mmol/l

1.3

0.75

420

1631

(3018010) Neutrophils/100 leukocytes in Blood

3925

30904

1.52

71.95

6.6

5.8

56.8

57.3

1.74

3664

28799

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1107

6393

1.85

70.26

1.9

1.7

—

(3021960) Folate [Moles/volume] in Serum or Plasma

2102

14492

1.61

69.55

1.6

1.5

nmol/l

21.9

20.6

1.70

1840

12273

(3000850) Epithelial cells [#/volume] in Urine

1896

12747

1.63

69.55

2.7

2.5

e6/l

5.5

6.0

0.81

1650

11066

(3022096) Basophils/100 leukocytes in Blood

3760

29477

1.51

69.46

6.8

6.0

0.7

1.39

3509

27407

(3002030) Lymphocytes/100 leukocytes in Blood

3957

31427

1.50

68.16

6.8

6.0

28.3

27.9

1.46

3684

29169

(3015377) Calcium [Moles/volume] in Serum or Plasma

2988

22412

1.52

67.58

2.9

3.6

mmol/l

2.4

0.28

2620

19501

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1099

6404

1.83

67.56

1.9

1.7

—

(3019309) Folate [Moles/volume] in Red Blood Cells

1716

11338

1.65

67.13

1.8

1.7

nmol/l

1176.1

1147.6

0.66

1348

8420

(3036481) Cortisol [Moles/volume] in Serum or Plasma

963

5439

1.87

65.29

2.1

2.3

nmol/l

354.0

383.2

4.43

872

5016

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1956

13424

1.60

65.29

1.3

1.2

u/ml

1.1

2.0

3.72

551

3547

(42870588) Differential panel, method unspecified - Blood

2920

21933

1.51

64.89

6.5

5.8

—

(4010399)

825

4459

1.95

63.88

1.5

1.4

—

(3000475) Leukocytes [#/volume] in Synovial fluid

347

1322

2.70

62.17

1.8

1.5

e6/l

11606.6

15899.1

1.02

255

927

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1252

7771

1.72

61.48

8.2

6.2

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

7824

73533

2.36

60.76

12.5

9.9

u/l

25.9

26.2

1.13

7628

70711

(3008898) HLA-B27 [Presence]

382

1559

2.52

59.48

1.1

1.0

—

(3048689) Calprotectin [Mass/mass] in Stool

1156

7116

1.73

58.24

2.1

2.2

ug/g

129.2

135.5

0.26

914

5547

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

897

5136

1.84

57.84

2.6

ml/min/173m2

68.8

65.0

1.97

361

1975

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1767

12171

1.58

56.90

4.2

3.4

ng/l

258.0

559.7

2.17

1351

9449

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

651

3380

2.01

56.35

7.3

10.3

—

(3018095) Leukocytes [#/volume] in Urine

2905

22451

1.45

53.05

4.2

3.4

e6/l

90.7

109.9

0.60

2173

15360

(3007461) Platelets [#/volume] in Blood

8009

76542

2.88

51.73

26.5

19.0

e9/l

257.1

252.7

7.86

7902

74305

(3024731) MCV [Entitic volume]

8012

76593

2.90

51.58

26.3

18.9

91.4

91.0

13.61

7955

75373

(3035941) MCH [Entitic mass]

8011

76582

2.89

51.51

26.3

18.9

30.4

30.3

8.56

7955

75362

(3026361) Erythrocytes [#/volume] in Blood

8012

76601

2.90

51.41

26.4

19.0

e12/l

4.4

4.5

23.29

7890

74129

(3010813) Leukocytes [#/volume] in Blood

8012

76611

2.89

51.21

26.4

19.0

e9/l

6.8

6.6

12.23

7893

74137

(3000963) Hemoglobin [Mass/volume] in Blood

8012

76623

2.88

50.96

26.5

19.1

g/l

134.1

135.4

13.71

7951

75408

(3015171) Extractable nuclear Ab [Units/volume] in Serum

464

2220

2.16

49.89

1.3

1.2

u/ml

0.9

0.09

157

(3002582) Erythrocytes [#/volume] in Urine

2504

19012

1.46

49.32

3.6

3.0

e6/l

51.6

81.4

1.21

1989

14208

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

7492

70041

1.80

48.25

5.4

4.8

mmol/l

2.8

7.30

6994

64300

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

837

4948

1.77

48.08

2.4

2.2

ug/l

5.4

8.2

6.11

745

4311

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

502

2519

2.06

47.58

5.5

5.2

1.8

1.6

3.28

474

2358

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

869

5210

1.75

47.50

3.0

2.7

ng/l

142.6

194.7

5.25

791

4743

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

750

4322

1.81

46.92

1.6

—

(40760892) CBC W Ordered Manual Differential panel - Blood

1928

14027

1.49

46.78

4.8

4.4

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1518

10502

1.55

46.76

3.3

3.5

mmol/l

0.8

0.05

1415

9827

(3020891) Body temperature

457

2236

2.11

46.32

4.7

4.8

—

(36304419) Bacteria [Presence] in Urine

2251

16938

1.45

45.78

3.4

2.9

—

(3022948) Iron [Moles/volume] in Serum or Plasma

1420

9725

1.56

45.66

2.5

umol/l

12.9

13.0

0.24

1314

9022

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

791

4687

1.76

44.94

3.6

3.9

ng/l

82.3

92.9

2.46

687

4028

(3007164) IgA [Mass/volume] in Serum or Plasma

1662

11826

1.51

44.65

1.5

1.4

g/l

2.3

2.4

2.10

1019

7087

(3030467) Casts [#/volume] in Urine by Automated count

2295

17400

1.44

44.60

3.5

2.9

e6/l

0.4

1.02

1775

12745

(3018405) Lactate [Moles/volume] in Arterial blood

416

2000

2.14

44.12

4.0

4.2

mmol/l

1.4

0.47

411

1968

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

7361

68743

1.68

44.09

4.9

4.3

mmol/l

4.7

4.8

4.54

6896

63435

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1219

8143

1.58

43.51

4.9

6.0

mmol/l

1.0

0.16

1123

7607

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

4761

40977

1.39

43.49

2.9

2.7

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

482

2474

2.01

42.84

5.6

5.3

1.0

0.9

7.67

454

2316

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

5120

44664

1.39

42.69

3.6

2.9

u/l

51.9

48.0

1.94

4792

41484

(3043409) Potassium [Moles/volume] in Arterial blood

368

1719

2.19

41.97

4.3

4.4

mmol/l

3.8

3.9

1.34

354

1598

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1861

13697

1.46

41.85

1.7

1.6

pmol/l

43113827.9

31117272.3

0.34

1561

11264

(3005322) IgE [Units/volume] in Serum or Plasma

630

3568

1.83

41.56

1.4

1.3

u/ml

186.6

236.1

0.82

585

3280

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2711

21397

1.40

41.26

3.4

3.2

u/l

32.7

36.1

1.34

2575

20240

(3009508) Creatinine [Moles/volume] in Urine

2624

20599

1.40

41.21

3.0

3.1

mmol/l

7.2

7.4

1.15

2204

17268

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

7303

68263

1.63

41.11

4.8

4.3

mmol/l

1.5

3.27

6822

62678

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1650

11914

1.48

40.75

2.6

3.2

mmol/l

2.4

2.5

2.18

1420

10455

(3004588) Protein electrophoresis panel - Serum or Plasma

688

4024

1.77

40.74

2.4

2.2

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1306

8998

1.54

40.37

2.4

2.5

g/l

2.4

2.3

4.77

1203

8325

(3033658) Prothrombin time (PT) actual/Normal

2192

16786

1.42

39.32

3.8

94.2

91.0

7.61

2123

16392

(3020630) Protein [Mass/volume] in Serum or Plasma

798

4932

1.68

38.68

2.8

2.6

g/l

66.6

66.4

0.38

729

4492

(3044941) Cell count panel - Synovial fluid

222

858

2.63

38.66

1.5

1.4

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

7085

65939

1.54

38.58

4.3

3.9

mmol/l

1.4

1.3

14.65

6584

60121

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

322

1490

2.21

37.58

1.6

1.4

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

358

1738

2.11

36.98

1.5

1.4

ug/g

286.6

272.9

0.62

207

1018

(3000494) Fungus identified in Specimen by Culture

1103

7456

1.55

36.90

1.6

1.4

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1214

8417

1.52

36.08

2.5

2.6

21.9

22.7

1.14

987

7236

(3014576) Chloride [Moles/volume] in Serum or Plasma

1132

7773

1.53

35.13

6.7

7.3

mmol/l

104.2

104.5

1.02

1102

7601

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1464

10623

1.46

34.57

3.1

2.6

e6/l

1.1

1.5

0.80

880

5841

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

256

1123

2.32

33.96

1.8

1.6

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1409

10199

1.46

33.59

1.6

1.4

—

(3012516) Albumin [Mass/volume] in Urine

2460

19609

1.36

33.55

3.1

3.2

mg/l

722.7

341.7

2.12

1511

12029

(3025941) Bacteria identified in Stool by Culture

568

3335

1.76

33.01

1.4

1.2

—

(3005719) IgG [Mass/volume] in Serum or Plasma

727

4574

1.65

32.68

2.9

2.7

g/l

10.1

10.6

1.53

670

4196

(40758558) Short blood count panel - Blood

2115

16553

1.37

32.09

6.4

7.1

—

(3022217) INR in Platelet poor plasma by Coagulation assay

1142

8000

1.50

31.99

22.7

23.4

inr

1.2

1.3

1.45

183

1180

(3020682) Albumin/Creatinine [Ratio] in Urine

2561

20698

1.34

31.44

3.6

4.0

mg/mmol

7.1

8.9

1.28

1544

12752

(3026782) Osmolality of Urine

1608

12099

1.41

30.69

2.8

2.6

mosm/kgh2o

518.2

543.0

4.46

1350

10230

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1330

9688

1.44

30.36

2.0

2.1

29.1

29.8

4.32

1287

9404

(3014111) Lactate [Moles/volume] in Serum or Plasma

800

5248

1.58

30.19

6.2

7.5

mmol/l

1.4

1.3

0.25

777

5086

(3021788) Differential panel - Synovial fluid

233

1048

2.26

29.18

1.6

1.5

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

643

4078

1.63

27.87

2.4

2.3

au/ml

29.5

23.6

0.34

271

(3027945) Reticulocytes/100 erythrocytes in Blood

978

6817

1.49

27.81

2.5

2.6

1.8

0.14

860

6046

(3045414) Leukocytes [Presence] in Urine

467

2728

1.75

27.57

2.2

1.8

—

(3021589) Normoblasts [#/volume] in Blood

3448

29433

1.30

27.54

10.1

9.2

e9/l

0.0

0.01

2906

23892

(3002385) Erythrocyte distribution width [Ratio]

6134

56517

1.34

27.40

20.4

16.0

13.8

13.7

2.46

6050

55237

(3010144) Erythrocytes [#/volume] in Synovial fluid

139

507

2.77

27.21

1.6

1.4

e6/l

180625.2

154358.9

0.13

340

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

992

6965

1.48

27.18

1.6

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

314

1626

1.97

27.17

1.2

1.1

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

169

685

2.50

26.78

1.7

1.5

52.5

57.2

0.75

102

431

(42529406) Shigella sp [Presence] in Stool by Culture

316

1652

1.95

26.60

1.2

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

590

3707

1.64

26.53

1.3

au/ml

54.7

49.0

0.18

184

(3014765) Yersinia sp identified in Stool by Organism specific culture

315

1647

1.95

26.51

1.2

1.1

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

587

3715

1.62

25.62

3.4

3.5

kpa

5.1

5.2

0.12

544

3436

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

182

784

2.35

25.25

6.9

6.6

mg/l

12.0

11.6

0.54

175

728

(3026389) Candida sp identified in Specimen by Organism specific culture

196

872

2.28

25.24

1.5

1.3

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

645

4209

1.58

24.75

1.3

1.2

—

(3009343) pH of Capillary blood

577

3668

1.62

24.71

3.4

3.5

7.4

0.17

484

(3000991) Gas panel - Venous blood

755

5114

1.52

24.49

7.0

8.8

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

557

3520

1.62

24.43

3.3

3.5

mmol/l

1.8

0.12

414

2644

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

278

3.26

23.63

1.6

1.5

u/l

4.9

6.7

2.28

238

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

327

1799

1.85

23.57

1.7

1.8

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1025

7464

1.43

22.93

1.9

1.7

1.6

1.4

5.77

887

6568

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

412

2449

1.72

22.84

1.1

u/ml

7.8

—

(3013512) EKG study

2350

19428

1.29

22.83

4.1

3.6

—

(3023520) Reticulocytes [#/volume] in Blood

734

5034

1.50

22.38

2.4

2.6

e9/l

70.7

70.5

0.05

575

3752

(3028026) IgM [Mass/volume] in Serum or Plasma

560

3636

1.58

21.91

1.9

g/l

1.4

0.04

505

3303

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

302

1669

1.84

21.48

1.2

1.3

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

523

3372

1.59

21.08

1.5

1.4

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

349

2032

1.75

20.84

2.7

2.4

ug/l

290.3

638.2

2.40

324

1917

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

321

1827

1.79

20.73

1.7

1.6

g/l

1.2

0.64

305

1734

(3017181) Myelocytes/100 leukocytes in Blood

769

5410

1.46

20.60

3.9

4.2

0.8

1.0

1.00

197

1603

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

921

6701

1.42

20.58

3.4

3.2

—

(3022145) Colonoscopy Study observation

1002

7403

1.40

20.51

1.3

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

628

4249

1.52

20.39

1.8

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

780

5519

1.46

20.26

3.9

3.8

kpa

5.9

5.8

2.77

754

5354

(36660697) Celiac disease serology panel - Serum

699

4841

1.49

20.26

1.2

1.1

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

310

1763

1.79

20.08

1.7

1.6

g/l

0.2

1.40

293

1671

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

6895

65390

1.34

20.08

15.0

12.3

ml/min/173m2

81.0

80.4

1.63

5900

53533

(3002179) Metamyelocytes/100 leukocytes in Blood

707

4918

1.48

20.04

3.6

4.0

0.5

0.7

0.78

141

1176

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

122

488

2.52

19.99

1.5

1.8

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

2208

18384

1.27

19.67

1.7

1.6

mmol/l

1.4

4.13

1882

15313

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

498

3228

1.58

19.61

2.5

2.4

—

(3002032) Base excess in Venous blood by calculation

774

5514

1.45

19.37

3.9

mmol/l

2.1

1.9

0.84

632

4505

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

116

4.24

18.96

1.4

1.2

38.1

37.2

0.05

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

356

2140

1.69

18.96

2.6

2.2

g/l

3.0

3.1

1.00

264

1684

(3041096) Erythrocytes [Presence] in Urine by Automated

2081

17274

1.27

18.86

3.6

3.1

—

(3021440) Promyelocytes/100 leukocytes in Blood

728

5162

1.45

18.66

4.0

4.2

0.1

0.21

184

1503

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

372

2275

1.67

18.57

2.6

2.2

g/l

3.7

3.9

1.15

260

1644

(3034860) Kappa light chains.free [Mass/volume] in Serum

319

1876

1.73

18.41

3.7

3.1

mg/l

49.4

55.9

0.39

257

1506

(4034850)

327

1937

1.72

18.39

10.7

8.3

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

372

2281

1.66

18.38

2.6

2.2

g/l

7.5

0.07

267

1725

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

371

2279

1.66

18.21

2.6

2.2

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

318

1876

1.72

18.15

3.7

3.1

mg/l

53.2

45.7

0.17

254

1510

(3045424) Erythrocytes [Presence] in Urine

207

1073

1.95

17.97

1.7

1.5

—

(3025159) Blasts/100 leukocytes in Blood

685

4840

1.45

17.87

4.1

4.2

0.1

0.3

1.00

157

1279

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

673

4740

1.46

17.85

1.9

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1273

9977

1.33

17.69

3.4

2.7

e6/l

3.0

2.8

0.28

701

5217

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

382

2392

1.63

17.38

2.2

1.9

ug/l

2.5

2.3

0.15

349

2143

(3023419) Bacteria identified in Sputum by Culture

155

733

2.14

17.30

2.9

2.5

—

(3017732) Neutrophils [#/volume] in Blood

634

4453

1.46

17.05

2.9

3.0

e9/l

3.9

4.0

0.48

497

3405

(3024263) Appearance of Synovial fluid

282

2.85

16.85

1.9

1.6

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

306

1832

1.70

16.58

3.7

3.1

ratio

1.9

2.5

0.31

131

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

323

1962

1.67

16.57

1.5

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

336

2066

1.65

16.45

2.8

2.7

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

525

3582

1.50

16.34

1.7

1.6

—

(3022313) Gas panel - Capillary blood

416

2705

1.57

16.17

3.6

3.5

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

576

4012

1.47

16.17

2.5

2.1

nmol/l

12.5

13.0

0.89

502

3613

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

973

7434

1.35

15.96

2.5

2.7

umol/l

7.7

8.9

0.97

834

6440

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

235

1320

1.80

15.94

1.4

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

242

1372

1.79

15.91

1.4

u/l

12.9

12.0

0.33

206

1118

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

202

1085

1.88

15.81

2.1

1.8

pmol/l

189.7

203.7

1.34

188

1035

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

367

2330

1.60

15.80

3.7

mmol/l

24.9

0.10

343

2154

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

449

2994

1.53

15.58

1.1

1.0

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

406

2650

1.56

15.52

3.3

2.8

0.6

0.7

1.44

377

2554

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

489

3323

1.50

15.52

7.2

9.7

mmol/l

24.4

24.3

0.35

459

3127

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

288

1735

1.68

15.27

1.3

1.2

u/ml

13.0

44.4

1.94

120

(44790048)

136

643

2.13

15.25

1.6

1.5

—

(44790049)

136

643

2.13

15.25

1.6

1.5

—

(44790047)

136

643

2.13

15.25

1.6

1.5

—

(44806118)

136

643

2.13

15.25

1.6

1.5

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

113

497

2.29

15.12

1.6

1.5

33.3

31.7

0.15

294

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

406

2671

1.55

14.99

2.0

u/l

39.6

39.1

0.20

367

2358

(3003338) MCHC [Mass/volume]

6141

57950

1.24

14.93

23.8

16.5

g/l

332.3

332.1

0.98

6106

57557

(3024354) Oxygen [Partial pressure] in Venous blood

621

4465

1.42

14.69

3.5

3.1

kpa

4.7

4.6

0.13

598

4318

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

160

815

1.98

14.68

1.4

1.3

u/l

32.2

34.7

0.39

127

663

(40757494) Bilirubin.total [Moles/volume] in Blood

304

2.65

14.67

1.9

2.2

umol/l

12.8

27.2

—

(3003327) Ova and parasites identified in Stool by Light microscopy

320

2006

1.62

14.54

1.7

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

266

1594

1.69

14.41

1.3

u/ml

5.4

8.0

0.58

280

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

337

2150

1.59

14.24

2.7

2.2

g/l

9.7

10.4

2.24

276

1806

(3009445) Proteinase 3 Ab [Units/volume] in Serum

402

2670

1.53

14.22

1.2

1.6

u/ml

5.8

17.1

—

(21494755) Public health laboratory ask at order entry panel

465

6654

0.68

14.22

1.3

1.4

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

220

1256

1.77

14.17

1.3

1.2

u/ml

27.3

44.2

1.18

131

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

310

1945

1.62

14.04

2.7

2.3

g/l

1.0

0.9

0.16

266

1659

(46235355) HIV 1 and 2 tests - Meaningful Use set

1138

9059

1.30

13.86

1.7

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

432

2932

1.50

13.81

1.3

1.4

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

513

3604

1.45

13.77

3.8

3.3

g/l

128.6

128.3

0.10

500

3519

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

576

4136

1.42

13.73

3.1

3.4

pmol/l

4.4

0.13

507

3690

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

261

1577

1.68

13.72

1.3

1.2

u/ml

2.7

4.1

0.62

175

(3000492) Spirometry study

808

6137

1.35

13.70

1.6

1.5

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

283

1747

1.64

13.69

1.6

iu/ml

0.1

0.9

1.09

373

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

316

2008

1.60

13.59

1.6

1.7

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

460

3175

1.48

13.53

2.7

2.5

e6/l

0.3

0.18

445

3075

(3044927) Protein electrophoresis panel - Urine

119

565

2.12

13.26

1.3

1.2

—

(40768804) Tissue Pathology biopsy report

3180

28391

1.20

13.23

2.1

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

278

1727

1.63

13.13

2.6

2.2

g/l

0.0

0.07

258

1562

(3037756) Immunofixation for Serum or Plasma

215

1248

1.74

13.10

1.6

1.7

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

846

6514

1.33

13.07

1.5

1.6

—

(3026470) Cobalt [Mass/volume] in Blood

347

2.44

13.01

2.3

2.0

ug/l

4.1

3.7

0.20

303

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

222

1305

1.72

12.94

1.3

1.2

u/ml

1.9

4.0

0.65

103

(3015235) Bicarbonate [Moles/volume] in Capillary blood

240

1443

1.68

12.88

2.7

3.1

mmol/l

24.7

24.9

0.43

209

1252

(40760888) Immunoglobulin light chains.free panel - Serum

236

1417

1.69

12.73

3.8

3.2

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

170

929

1.85

12.69

1.2

1.4

—

(3017704) Immunofixation for Urine

322

2.47

12.61

1.8

1.6

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

910

7129

1.31

12.42

3.8

4.5

u/l

239.9

244.1

0.41

853

6768

(3019225) pH of Specimen

851

6610

1.32

12.35

4.6

4.1

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

2066

17805

1.21

12.34

4.9

4.6

ug/l

1.9

3.1

3.34

1880

16023

(3020961) Endomysium IgA Ab [Titer] in Serum

402

2759

1.48

12.18

1.1

titre

331.9

210.4

—

(3025577) Chromium [Mass/volume] in Blood

337

2.39

11.91

2.4

2.1

ug/l

2.3

2.7

0.39

276

(3011985) Renin [Units/volume] in Plasma

159

869

1.85

11.90

1.5

1.4

mu/l

70.3

63.5

0.15

141

768

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

273

1734

1.59

11.81

2.1

2.0

mg/l

10.9

11.5

0.55

254

1618

(3022621) pH of Urine by Test strip

563

4133

1.39

11.81

3.3

2.9

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

774

5972

1.33

11.76

2.6

2.4

u/l

33.4

51.3

1.38

652

5149

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

236

1452

1.64

11.63

1.6

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

225

1370

1.66

11.55

1.2

1.3

mg/l

505.6

497.4

0.12

210

1307

(3011288) Drugs identified in Urine by Screen method

186

1076

1.75

11.53

2.7

2.6

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

398

2757

1.47

11.52

1.8

1.7

g/l

1.6

0.54

355

2364

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

315

2091

1.53

11.24

1.5

1.6

titre

75.0

369.5

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

141

3.13

11.07

1.6

1.5

ug/l

0.4

0.13

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

227

1407

1.63

10.89

1.6

1.7

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

200

1202

1.68

10.82

1.2

1.4

e6/l

7.7

28.4

1.15

159

902

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

200

1203

1.68

10.78

1.2

1.5

e6/l

1569.6

987.6

0.36

167

963

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1660

14170

1.21

10.71

4.4

4.0

22.0

21.7

0.28

715

6733

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

238

1501

1.60

10.65

1.2

1.1

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

113

573

1.99

10.63

1.6

1.3

g/l

5.8

6.9

3.08

391

(3006184) Hemoglobin [Mass/volume] in Capillary blood

223

1385

1.63

10.62

2.2

g/l

126.9

128.7

0.45

154

971

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

180

1058

1.72

10.58

1.6

1.5

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

241

1528

1.59

10.55

2.1

1.7

nmol/l

37.7

41.5

2.36

229

1484

(4062490)

112

568

1.99

10.54

1.6

1.3

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

404

2857

1.44

10.51

4.1

4.3

mmol/l

24.4

24.1

0.71

353

2596

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

373

2599

1.46

10.50

3.7

3.8

53.3

47.4

4.59

368

2566

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

275

1800

1.55

10.48

2.5

2.1

g/l

37.9

37.5

0.53

235

1538

(3027273) Bicarbonate [Moles/volume] in Venous blood

400

2827

1.44

10.44

3.4

3.3

mmol/l

25.3

25.1

0.57

385

2745

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

403

2.17

10.42

1.3

u/ml

0.4

1.5

1.09

183

(3024139) IgG subclass 3 [Mass/volume] in Serum

112

573

1.97

10.29

1.6

1.3

g/l

0.5

0.4

0.29

391

(3028192) IgG subclass 2 [Mass/volume] in Serum

112

574

1.96

10.24

1.6

1.3

g/l

2.7

3.0

1.34

393

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

343

2367

1.47

10.16

1.9

1.7

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

373

2616

1.45

10.15

2.1

1.9

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

368

2576

1.45

10.12

1.8

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

149

2.96

10.11

1.5

1.3

54.6

54.0

0.03

130

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

249

1608

1.57

10.09

1.1

u/ml

3.1

7.0

1.11

209

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

509

3777

1.37

10.01

5.2

7.4

mmol/l

24.7

24.8

0.17

500

3745

(3021387) Prolactin [Units/volume] in Serum or Plasma

259

1694

1.55

9.93

1.8

1.7

mu/l

274.5

320.8

2.16

238

1537

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

178

2.76

9.93

1.2

1.3

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

225

2.54

9.82

1.9

1.7

umol/l

109.8

125.2

0.18

107

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

355

2.21

9.78

1.3

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

136

755

1.81

9.76

1.2

1.3

nmol/l

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

137

763

1.81

9.73

1.2

u/ml

62.2

61.1

0.02

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

356

2.20

9.72

1.3

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

143

812

1.77

9.53

1.3

pmol/l

311.2

326.2

0.12

112

610

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

251

1646

1.54

9.53

1.4

1.3

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

156

912

1.72

9.40

1.4

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

247

1620

1.54

9.37

2.7

2.2

g/l

0.0

0.09

227

1462

(3020191) Ethanol [Moles/volume] in Serum or Plasma

441

2.05

9.36

1.5

1.3

promille

1.5

1.2

0.79

334

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

192

1188

1.63

9.34

1.1

1.3

mmol/l

3.7

3.8

0.17

175

1118

(44813793)

391

2.11

9.18

1.1

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

257

2.38

9.17

2.0

1.7

nmol/l

2.8

14.3

0.66

214

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

149

869

1.73

9.07

1.2

1.3

nmol/l

0.2

0.03

(3024980) IgG subclass 4 [Mass/volume] in Serum

157

930

1.70

9.04

1.6

g/l

0.7

0.8

0.81

115

698

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

149

870

1.73

9.03

1.2

1.3

nmol/l

0.7

2.4

0.69

144

836

(3024869) Neuronal Ab [Presence] in Serum

3.34

9.01

1.1

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

401

2.08

8.98

1.3

1.1

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

242

1597

1.53

8.95

2.7

2.2

g/l

0.0

0.00

227

1460

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

219

1418

1.56

8.83

1.6

—

(21494890) Protein electrophoresis panel - 24 hour Urine

109

584

1.88

8.80

2.5

2.2

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

134

2.92

8.78

1.2

1.3

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

336

2384

1.43

8.64

1.6

—

(1761868) Lipid panel - Serum or Plasma

2302

25649

0.86

8.63

2.8

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

947

7789

1.24

8.61

1.6

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

329

2.17

8.57

1.1

nmol/l

2.4

11.7

1.10

(3049717) Cytology report of Urine Cyto stain

307

2147

1.45

8.54

2.3

2.7

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

404

2.04

8.45

1.9

2.1

nmol/l

18.3

17.3

0.52

379

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

778

6275

1.26

8.39

2.1

2.2

g/l

0.2

1.18

719

5851

(3030313) Adrenal Ab [Titer] in Serum

5.78

8.32

1.1

—

(3052851) Hemolysis interference index of Serum or Plasma

273

1879

1.47

8.27

2.8

3.2

—

(3044290) Cell count panel - Cerebral spinal fluid

182

1147

1.60

8.26

1.2

1.4

—

(3035637) Corticotropin [Mass/volume] in Plasma

132

766

1.74

8.22

1.6

1.5

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

390

2.04

8.12

1.5

1.6

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

439

1.97

8.05

1.5

u/ml

15.0

19.9

0.82

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

127

738

1.73

7.89

1.8

2.1

mg/l

50.3

27.4

1.75

201

(3004616) Nuclear Ab [Presence] in Serum

130

763

1.72

7.80

1.5

1.3

—

(3045716) Anion gap in Serum or Plasma

252

2.27

7.75

4.8

2.5

mmol/l

8.4

9.3

1.15

195

(3024928) Oxygen saturation in Venous blood

193

1257

1.55

7.64

4.4

3.5

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

496

6365

0.77

7.56

1.8

—

(40767503) Oxygen content in Capillary blood by calculation

198

1301

1.53

7.54

2.3

2.5

16.4

16.2

0.26

657

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

124

2.83

7.51

1.4

1.3

mg/l

0.8

93.4

0.99

(44816559) Phosphatidylethanol [Mass/volume] in Blood

167

1057

1.59

7.49

1.3

—

(3020779) Urea [Moles/volume] in Serum or Plasma

700

5657

1.26

7.43

7.3

7.7

mmol/l

9.3

9.7

1.05

664

5391

(40768443) Skin Pathology biopsy report

391

2923

1.35

7.40

1.3

1.2

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

3.26

7.36

2.1

1.5

—

(3028707) Methadone [Presence] in Urine by Screen method

116

671

1.74

7.36

2.4

2.5

—

(3014051) Protein [Presence] in Urine by Test strip

203

1350

1.52

7.32

2.7

2.1

—

(3007566) Smooth muscle Ab [Titer] in Serum

257

1792

1.45

7.32

1.2

titre

160.6

166.4

0.02

154

(3034770) Mitochondria Ab [Titer] in Serum

255

1776

1.45

7.31

1.2

titre

548.3

892.4

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

138

844

1.65

7.13

1.3

1.2

mmol/l

7.0

7.5

0.71

105

622

(3034891) Synovial lining cells/100 cells in Synovial fluid

269

2.16

7.06

1.6

1.5

5.5

2.9

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

539

4255

1.29

6.94

1.2

iu/ml

134.9

154.3

0.53

211

1611

(3028626) Oxygen [Partial pressure] in Capillary blood

189

1254

1.52

6.92

2.8

3.0

kpa

8.2

8.1

0.25

174

1146

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

4.26

6.74

1.1

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1276

11059

1.18

6.69

1.5

1.4

—

(3003181) Sodium [Moles/volume] in Urine

166

1083

1.54

6.58

1.3

mmol/l

60.4

63.4

0.48

130

861

(4027681)

271

2.11

6.55

1.2

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

131

813

1.62

6.44

1.5

1.4

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

191

1291

1.49

6.43

2.1

1.9

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

141

2.56

6.42

1.3

1.4

nmol/l

186.8

117.4

1.03

(3010421) pH of Blood

230

1617

1.43

6.32

2.9

3.9

7.4

0.12

188

1367

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

515

1.78

6.29

1.2

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

127

789

1.62

6.23

1.2

1.3

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

402

1.87

6.18

1.7

2.7

e6/l

465.0

495.9

0.19

342

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

233

1651

1.42

6.15

1.7

1.8

iu/l

5.0

5.4

0.20

613

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

145

2.49

6.08

1.8

1.9

mg/l

7.8

9.9

1.63

118

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

267

2.07

6.02

1.5

1.9

141.0

152.4

0.51

251

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

128

804

1.60

6.02

1.4

1.5

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

131

828

1.59

6.00

1.5

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

128

805

1.60

5.99

1.4

1.5

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

134

852

1.58

5.99

1.6

1.5

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

4.52

5.97

1.0

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

2.89

5.87

1.3

1.2

—

(3021901) Oxygen saturation in Capillary blood

158

1048

1.52

5.86

2.8

3.0

—

(4035726)

558

6841

0.80

5.84

1.4

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

167

2.34

5.79

1.2

98.5

87.3

1.14

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

158

1051

1.51

5.78

1.1

u/ml

0.8

1.3

0.50

380

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

161

2.37

5.78

2.3

3.1

mg/l

7.9

8.5

0.23

132

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

390

1.85

5.77

1.8

2.7

e9/l

0.2

0.01

341

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

164

1103

1.50

5.70

1.3

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

106

646

1.65

5.65

1.5

1.7

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

126

803

1.58

5.60

1.4

1.5

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

116

725

1.61

5.60

3.2

4.0

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

128

822

1.57

5.52

1.4

1.5

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

600

1.66

5.41

1.6

1.8

—

(1616796) Gas panel - Central venous blood

192

1347

1.44

5.40

3.0

3.6

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

286

1.96

5.37

1.1

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

173

2.26

5.37

1.2

1.1

97.7

87.4

1.39

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

259

2.01

5.35

1.0

1.1

u/l

1.0

1.1

1.77

127

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

126

813

1.56

5.33

1.4

1.5

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

148

990

1.50

5.31

1.1

1.2

—

(3012501) Base excess in Blood by calculation

197

1396

1.42

5.26

2.7

3.9

mmol/l

2.1

2.6

2.39

132

961

(3013290) Carbon dioxide [Partial pressure] in Blood

197

1398

1.42

5.22

2.7

3.9

kpa

5.0

0.40

188

1368

(3027315) Oxygen [Partial pressure] in Blood

198

1408

1.42

5.19

2.7

3.9

kpa

8.5

8.6

0.28

189

1378

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

154

1045

1.48

5.17

1.6

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

245

1810

1.36

5.12

1.9

1.7

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

372

1.81

5.02

1.1

mg/l

38.4

42.4

0.45

306

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

167

2.22

4.92

2.1

1.6

ug/l

9.5

8.5

0.73

167

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

331

4224

0.77

4.90

1.4

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

362

1.80

4.83

1.0

1.1

mg/l

260.0

257.0

0.05

313

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

270

2047

1.33

4.79

1.7

1.8

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

660

5558

1.20

4.78

3.4

3.8

mmol/l

1.2

0.28

583

4819

(3023323) Follitropin [Units/volume] in Serum or Plasma

352

2769

1.28

4.76

1.4

1.3

iu/l

32.4

34.6

0.57

308

2383

(3021879) Hepatitis B virus core Ab [Presence] in Serum

519

4271

1.23

4.75

1.4

—

(3036670) Protein [Mass/volume] in Synovial fluid

170

2.18

4.73

1.2

1.3

g/l

41.0

39.1

0.28

(3028271) Lactate [Moles/volume] in Capillary blood

144

985

1.47

4.68

1.6

1.8

mmol/l

1.7

0.06

139

963

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

625

1.59

4.65

1.2

—

(3016879) Cocaine [Presence] in Urine

215

1583

1.37

4.63

2.1

1.9

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

533

1.64

4.62

1.6

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

533

1.64

4.62

1.6

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

533

1.64

4.62

1.6

1.7

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

110

713

1.55

4.62

1.0

1.1

u/ml

3.5

0.00

269

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

234

1747

1.35

4.61

1.6

1.5

iu/ml

13.5

18.4

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

511

1.65

4.59

1.3

1.2

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

581

1.61

4.57

3.2

2.8

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

141

966

1.47

4.56

1.1

u/ml

5.8

4.8

0.24

457

(3023183) Ammonium ion [Moles/volume] in Plasma

177

1268

1.40

4.50

2.1

2.8

umol/l

32.5

35.1

0.48

154

1098

(3017354) Segmented neutrophils/100 leukocytes in Blood

104

670

1.56

4.50

2.8

3.5

59.1

57.6

0.29

442

(3009542) Hematocrit [Volume Fraction] of Blood

6444

62762

1.12

4.49

18.6

14.1

39.5

39.7

1.21

4288

45655

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

285

1.87

4.44

1.2

1.3

70.4

60.0

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

395

1.73

4.42

1.2

1.4

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

188

1368

1.38

4.38

2.3

2.1

u/l

2057.2

4777.2

1.52

528

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

405

1.71

4.33

1.2

1.4

—

(3019832) Treponema pallidum Ab [Presence] in Serum

465

3823

1.23

4.32

1.5

1.6

—

(3037121) Protein [Mass/volume] in Urine

282

2185

1.30

4.32

2.7

3.2

g/l

0.3

0.02

107

916

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

197

2.04

4.31

1.2

1.1

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

528

1.62

4.30

1.1

1.3

—

(3000060) B lymphocytes [#/volume] in Blood

139

2.23

4.23

1.4

2.2

e6/l

228.4

331.7

0.24

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

341

1.77

4.22

1.1

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

135

933

1.45

4.21

1.1

u/ml

0.5

1.5

1.83

366

(40761536) Microorganisms panel - Urine sediment

650

5535

1.19

4.19

4.0

3.7

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

248

1.90

4.18

2.4

2.2

—

(3020876) Protein [Mass/time] in 24 hour Urine

509

1.62

4.17

2.0

g/24h

0.3

1.1

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

170

1228

1.39

4.16

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

170

1228

1.39

4.16

1.3

—

(3003694) ABO and Rh group [Type] in Blood

1977

18191

1.11

4.15

1.4

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

113

757

1.50

4.12

1.0

u/ml

2.5

3.2

0.35

277

(3048929) Epstein Barr virus Ab [Presence] in Serum

225

1703

1.33

4.09

1.1

1.2

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

174

1269

1.38

4.03

2.4

3.1

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

325

1.76

3.99

1.6

2.3

100.9

95.4

0.53

306

(3000764) Benzodiazepines [Presence] in Urine

226

1719

1.32

3.98

2.0

1.8

—

(4281824)

963

0.59

3.94

1.1

1.2

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

112

2.33

3.91

1.3

1.1

—

(3028300) Cannabinoids [Presence] in Urine

227

1735

1.32

3.88

2.1

1.8

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

3.80

1.1

1.3

—

(4094501)

241

1866

1.30

3.76

1.1

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

134

2.17

3.72

1.1

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

209

1.92

3.71

1.4

1.5

pmol/l

14.9

16.3

0.70

183

(3027008) Opiates [Presence] in Urine

225

1732

1.31

3.67

2.0

1.8

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

212

1621

1.32

3.64

1.4

1.3

miu/ml

207.7

223.6

0.22

716

(3008295) Osmolality of Serum or Plasma

632

1.51

3.63

1.3

1.4

mosm/kgh2o

277.2

279.9

0.53

508

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

117

2.23

3.56

1.2

1.1

99.1

76.3

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

390

1.65

3.56

1.6

1.3

titre

100.0

69.2

—

(4198724)

192

1.93

3.51

1.2

1.7

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

400

1.63

3.49

1.6

1.3

titre

341.1

427.9

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

123

869

1.42

3.48

1.1

u/ml

0.4

2.0

3.05

195

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

280

1.75

3.45

1.1

u/ml

1.9

8.9

—

(3038026) Centromere Ab [Units/volume] in Serum

519

1.55

3.45

1.4

1.2

u/ml

49.4

31.9

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

443

1.59

3.37

1.2

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

443

1.59

3.37

1.2

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

443

1.59

3.37

1.2

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

443

1.59

3.37

1.2

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

443

1.59

3.37

1.2

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

444

1.58

3.34

1.2

1.1

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

510

1.53

3.27

1.4

1.2

u/ml

69.8

36.9

—

(3027944) Amphetamines [Presence] in Urine

218

1704

1.29

3.22

2.1

1.8

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

333

1.66

3.18

1.8

u/field

2.5

2.9

0.13

238

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

117

2.14

3.15

1.2

1.1

82.5

77.9

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

334

1.65

3.14

1.5

nmol/l

1.4

1.3

0.16

259

(3018851) Theophylline [Moles/volume] in Serum or Plasma

2.96

3.13

2.7

1.8

umol/l

61.0

43.5

0.51

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

556

1.50

3.13

1.3

nmol/l

1.4

0.04

489

(1761482) Bacteria [#/volume] in Urine by Culture

125

1702

0.73

3.07

3.8

—

(3000034) Microalbumin [Mass/volume] in Urine

609

1.47

3.03

2.6

2.9

mg/l

14.9

55.4

2.08

441

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

331

1.64

2.99

2.0

2.8

u/ml

728.9

1280.3

2.15

326

(3016650) Hepatitis A virus Ab [Presence] in Serum

140

1040

1.35

2.99

1.1

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

370

1.60

2.99

1.2

ratio

1.0

1.1

1.40

139

(3011412) CD3 cells [#/volume] in Blood

603

1.46

2.98

1.8

2.4

e9/l

1.1

1.2

0.23

374

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

442

1.54

2.96

1.1

1.3

mmol/l

1.9

2.1

1.13

418

(3033923) Metanephrine [Moles/time] in 24 hour Urine

107

2.15

2.95

1.1

1.2

umol/24h

0.7

0.6

0.12

(3004809) Band form neutrophils/100 leukocytes in Blood

148

1112

1.34

2.94

3.1

3.4

1.2

1.5

0.62

114

877

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

287

1.68

2.93

4.4

3.9

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

272

1.70

2.93

1.1

1.0

98.3

95.5

0.24

221

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

581

1.47

2.92

1.4

—

(40762814) Titanium [Mass/volume] in Blood

101

2.18

2.92

2.4

2.3

ug/l

4.6

4.2

—

(3042631) Mycobacterium sp identified in Specimen

121

887

1.37

2.83

2.8

2.6

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

193

1.82

2.83

1.1

1.2

g/l

0.3

0.36

151

(3052592) Norovirus Ag [Presence] in Stool

116

2.07

2.82

1.3

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

337

1.61

2.81

1.2

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

2.26

2.76

2.6

2.1

—

(3007916) DNA double strand Ab [Titer] in Serum

2.26

2.76

1.7

1.1

—

318.0

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

117

2.05

2.76

6.5

7.4

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

142

1072

1.33

2.76

1.7

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

114

832

1.38

2.75

1.6

1.5

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

116

850

1.37

2.74

1.1

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

114

835

1.37

2.70

1.3

1.2

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

478

1.49

2.66

1.0

1.1

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.18

2.66

1.1

—

(40757373) Influenza virus identified in Isolate

119

2.02

2.65

1.9

1.7

—

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

119

2.02

2.65

1.5

1.2

120.3

105.9

0.89

111

(3038071) Oxygen [Partial pressure] in Mixed venous blood

147

1.91

2.64

6.0

7.8

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

107

779

1.38

2.64

1.3

1.2

u/l

56.3

64.0

0.81

506

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

281

1.64

2.63

1.3

1.1

—

(3019174) dRVVT (LA screen)

2.55

2.61

1.1

1.3

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

274

1.65

2.60

1.2

1.1

u/ml

19.8

6.0

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

120

2.00

2.60

2.0

1.7

ng/l

104.1

130.7

0.58

120

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

640

1.41

2.56

1.0

u/ml

0.0

0.8

1.10

129

(3023511) Choriogonadotropin [Units/volume] in Urine

657

1.40

2.55

1.3

1.2

—

(1002224) Polysomnography panel

329

2771

1.20

2.52

1.1

—

(3047189) Immunofixation for 24 hour Urine

270

1.63

2.48

2.0

2.1

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

172

1355

1.28

2.48

5.5

6.1

iu/ml

443.3

1940.8

0.79

216

(3038515) Glucose [Moles/volume] in Venous blood

1330

0.73

2.44

3.8

2.9

mmol/l

7.2

7.6

0.40

1302

(3024891) Influenza virus A+B Ag [Presence] in Specimen

197

1581

1.25

2.43

1.2

1.1

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

2.94

2.41

1.2

1.4

—

(3034988) Calcium [Moles/volume] in Capillary blood

103

2.04

2.41

1.6

2.1

mmol/l

1.2

0.35

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

2.17

2.40

1.3

1.7

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

556

1.42

2.40

1.3

1.6

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

105

776

1.36

2.39

3.1

3.6

nmol/l

7.4

13.0

0.31

762

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

566

1.42

2.36

4.2

3.8

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

434

1.48

2.36

1.8

2.7

e6/l

714.8

639.9

0.33

186

(3019230) Fractional oxyhemoglobin in Venous blood

137

1056

1.30

2.35

4.2

3.1

62.8

65.5

0.74

137

1050

(3002619) Bacteria identified in Specimen by Culture

111

1.98

2.35

1.4

1.3

—

(21491868) Cryoglobulin [Mass/volume] in Serum

213

1.69

2.35

1.1

g/l

—

0.3

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

140

1.86

2.31

2.1

2.4

mmol/l

6.7

8.0

1.06

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

478

1.45

2.29

1.6

2.0

17.6

14.4

1.01

194

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

185

1.73

2.27

1.2

1.1

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

430

1.47

2.26

1.4

1.2

u/l

22.6

20.9

0.12

353

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

2.28

2.24

1.3

nmol/l

0.1

0.3

—

(3016038) Potassium [Moles/volume] in Urine

399

1.48

2.22

1.0

1.2

mmol/l

30.5

36.1

1.15

347

(3001019) Free T4 and TSH panel - Serum or Plasma

303

3562

0.84

2.21

1.7

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.07

2.16

1.1

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

3.00

2.14

1.2

1.0

mmol/l

8.3

—

(3017569) Oxygen content in Arterial blood

290

1.55

2.13

1.8

2.1

—

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

322

1.52

2.12

2.6

2.7

ug/l

25.6

—

(3044009) aPTT.lupus sensitive (LA screen)

2.37

2.12

1.1

1.3

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

423

0.57

2.11

1.0

1.1

—

(3040151) Glucose [Moles/volume] in Capillary blood

640

1.36

2.09

7.8

5.6

mmol/l

6.8

7.8

1.99

537

(3044242) Glucose [Moles/volume] in Arterial blood

308

1.53

2.07

2.9

2.0

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

168

1.73

2.07

5.8

7.8

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

3.50

2.05

1.0

—

(3012565) Volume of 24 hour Urine

317

1.52

2.05

2.2

2193.2

1939.6

0.69

282

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

374

1.47

2.04

1.1

iu/ml

8.6

9.3

0.08

(3023410) Appearance of Cerebral spinal fluid

566

1.38

2.04

1.3

1.5

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

524

1.40

2.03

1.2

titre

86.0

190.6

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

350

1.49

2.03

2.1

2.9

42.7

38.3

0.54

132

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

246

1.59

2.03

2.0

2.4

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

500

1.40

2.01

2.0

1.7

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

943

8668

1.10

2.01

4.7

4.4

32.1

32.4

0.40

683

5777

(3000093) Morphology [Interpretation] in Blood Narrative

568

1.38

2.00

1.1

—

(3008037) Lactate [Moles/volume] in Venous blood

108

1399

0.77

2.00

3.6

2.9

mmol/l

1.4

1.6

3.00

103

1364

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

223

1859

1.21

1.98

3.1

2.5

g/l

3.6

0.11

212

1767

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

178

1.69

1.98

1.1

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

595

5344

1.12

1.97

1.4

1.3

—

(3004451) EKG impression Narrative

280

1.54

1.96

1.3

1.2

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

131

1032

1.27

1.96

1.1

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

2.08

1.96

1.0

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

112

1.88

1.95

1.2

2.1

umol/l

13.9

18.5

1.64

112

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

2.35

1.94

1.0

1.3

umol/24h

1.6

1.7

0.33

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

202

1.64

1.94

1.1

ng/l

68.5

663.1

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

109

840

1.30

1.93

1.1

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

218

1.61

1.93

3.0

2.9

umol/l

30.9

29.1

0.48

163

(3036489) Thrombin time

280

2390

1.18

1.92

2.2

2.0

21.3

21.5

0.29

227

2083

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

129

1018

1.27

1.91

1.5

1.2

u/l

30.4

31.7

0.07

118

872

(4024509)

616

1.35

1.91

1.6

1.5

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

189

1558

1.22

1.90

2.2

2.4

ug/min

84.9

93.8

0.16

103

959

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

340

1.47

1.88

1.6

1.9

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

204

1.62

1.88

1.1

1.2

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

300

1.50

1.86

1.3

1.5

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

300

1.50

1.86

1.3

1.5

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

369

0.57

1.86

1.7

1.4

—

(44806420)

197

0.46

1.83

2.3

2.4

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

2.12

1.81

1.0

1.1

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

155

1260

1.23

1.80

1.3

1.5

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

444

1.40

1.79

1.6

2.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

118

930

1.27

1.79

1.1

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

2.17

1.77

1.2

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

530

1.36

1.77

2.0

u/field

2.3

2.6

0.09

215

(3045683) HLA typing for celiac disease panel - Blood or Tissue

370

1.44

1.76

1.0

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

2.44

1.75

1.3

1.8

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

2.50

1.73

1.0

1.1

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

115

909

1.27

1.72

1.2

u/ml

2.8

3.8

0.73

391

(3027456) Digoxin [Moles/volume] in Serum or Plasma

148

1205

1.23

1.71

3.1

nmol/l

0.8

1.20

111

925

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

148

1.69

1.0

1.1

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

340

1.44

1.69

1.6

1.9

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

340

1.44

1.69

1.6

1.9

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

340

1.44

1.69

1.6

1.9

—

(3036603) Volume of Urine

449

1.38

1.69

1.6

1.7

1961.1

1952.4

0.01

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

207

1747

1.19

1.66

1.3

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

2.80

1.65

1.0

1.3

—

(40768795) Lymph node Pathology biopsy report

803

0.73

1.61

1.2

—

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

2.14

1.61

1.4

1.2

pmol/l

7.5

17.4

1.17

(3042010) Triglyceride [Moles/volume] in Pleural fluid

1.91

1.59

1.3

mmol/l

0.3

1.6

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

230

1.52

1.59

1.9

1.5

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

654

1.30

1.58

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

144

1.67

1.57

1.0

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

144

1.67

1.57

1.0

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

144

1.67

1.57

1.0

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

144

1.67

1.57

1.0

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

465

1.36

1.56

1.7

1.5

u/l

4.2

5.6

0.50

208

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

115

923

1.25

1.54

1.5

1.6

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

2.43

1.53

1.0

1.1

—

(3040893) Potassium [Moles/volume] in Capillary blood

3.33

1.52

1.2

1.7

mmol/l

4.5

—

(3048879) Bone marrow aspiration report

177

1.58

1.51

1.4

2.1

—

(3020650) Glucose [Presence] in Urine

177

1.58

1.51

1.4

1.3

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

108

1.76

1.50

1.2

mmol/l

1.5

1.9

0.70

(21494567) Legionella sp IgM Ab [Presence] in Serum

2.43

1.47

1.0

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

675

0.72

1.47

1.1

1.0

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

1.84

1.45

9.8

9.1

—

(40768793) Breast Pathology biopsy report

154

1839

0.83

1.45

1.3

—

(3039443) Prostate specific Ag panel - Serum or Plasma

1214

0.80

1.45

1.6

—

(4211845)

327

1.41

1.44

3.6

3.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

353

1.39

1.42

1.6

1.4

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

129

1060

1.22

1.42

1.5

1.6

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

103

1.75

1.40

1.5

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

150

1.60

1.37

1.2

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

511

1.31

1.37

1.3

mmol/l

11.5

11.7

0.08

141

(3010375) cycloSPORINE [Mass/volume] in Blood

314

1.40

1.36

28.8

27.2

ug/l

121.2

115.6

0.22

258

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

2.94

1.36

1.2

1.1

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

2.94

1.36

1.0

1.2

—

(3013293) Extractable nuclear Ab [Presence] in Serum

1.75

1.34

1.4

1.5

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

273

1.43

1.34

1.2

1.1

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

191

1.52

1.34

2.1

3.4

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.87

1.34

1.1

1.2

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

167

1.56

1.34

1.0

1.1

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

0.00

1.33

0.0

1.0

—

1.3

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

2.13

1.33

3.1

2.3

—

(40768806) Pleura Pathology biopsy report

731

0.75

1.33

1.5

—

(4306422)

113

926

1.22

1.30

1.2

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

275

1.42

1.30

1.6

2.1

—

(40768800) Prostate Pathology biopsy report

1141

0.80

1.30

1.3

1.2

—

(3042517) Benzodiazepines panel - Urine

2.35

1.29

2.8

2.5

—

(3037556) Urate [Mass/volume] in Serum or Plasma

177

1.53

1.28

1.3

1.4

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

170

1451

1.18

1.27

2.5

3.6

u/ml

506.9

591.3

0.07

157

1329

(3006922) Hepatitis E virus Ab [Presence] in Serum

448

1.32

1.26

1.0

1.1

—

(3035320) C reactive protein [Mass/volume] in Body fluid

448

1.32

1.26

2.9

2.2

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

414

1.33

1.25

1.0

ng/l

812.7

691.3

1.13

294

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

2.40

1.24

1.8

1.3

nmol/l

389.0

559.3

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.91

1.22

1.2

1.1

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

2.04

1.21

1.1

u/l

8.3

14.8

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

2.63

1.21

1.4

1.2

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

2.63

1.21

1.0

—

(3016184) Myelin associated glycoprotein Ab [Units/volume] in Serum

2.63

1.21

1.0

1.1

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

646

1.26

1.21

3.6

5.2

u/ml

75.2

100.5

0.21

187

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.80

1.21

1.1

1.2

—

(3006462) Nitrate [Presence] in Urine

305

1.38

1.20

3.8

3.2

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

417

1.32

1.20

1.0

ng/l

32.4

44.9

2.55

302

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

764

1.23

1.19

1.0

1.1

—

(3019977) pH of Arterial blood

358

1.34

1.17

2.7

2.4

7.4

0.52

132

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

113

939

1.21

1.16

1.2

u/ml

2.6

3.3

0.36

316

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

544

0.73

1.16

1.1

1.2

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

0.00

1.16

0.0

1.1

—

(3010937) Rubella virus Ab [Presence] in Serum

0.00

1.16

0.0

1.1

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

241

2129

1.14

1.16

4.2

2.9

u/ml

0.3

0.4

0.22

144

1214

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

257

1.40

1.15

2.3

2.9

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

232

1.42

1.14

1.3

1.2

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

412

1.31

1.14

1.0

ng/l

266.2

349.6

2.74

301

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

139

1180

1.18

1.14

1.2

—

(3016018) Differential panel - Cerebral spinal fluid

635

1.25

1.12

1.2

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

766

0.78

1.12

1.5

1.4

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

475

1.29

1.12

1.1

mg/l

290.2

289.5

0.02

425

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

2.00

1.12

1.0

1.1

—

(21494434) Karyotype in Bone marrow

555

1.26

1.12

1.1

1.2

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

2.26

1.10

1.1

1.6

umol/24h

315.0

367.6

—

(37021550) Renin [Units/volume] in Plasma --upright

136

1.55

1.08

1.3

mu/l

45.2

67.7

0.51

105

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

2.19

1.08

1.7

1.5

—

0.1

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.87

1.07

3.7

2.6

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

470

1.28

1.06

1.7

1.9

umol/l

8.9

9.8

0.11

351

(3022689) Creatine [Moles/volume] in Urine

194

1.44

1.06

1.4

1.6

—

(3001729) Color of Synovial fluid

1.92

1.06

1.2

1.5

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

137

1.53

1.05

1.2

1.1

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

121

1.57

1.05

2.4

2.1

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

142

1219

1.17

1.04

1.1

1.3

—

(3010015) Selenium [Moles/volume] in Serum or Plasma

1.92

1.02

1.6

1.9

umol/l

1.4

—

(3050794) Legionella sp Ab [Presence] in Serum

1.92

1.02

1.0

1.2

—

(4015189)

163

1.47

1.01

3.0

2.0

—

(3028717) Thiamine [Mass/volume] in Blood

1.89

1.01

1.1

1.2

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

273

1.36

1.00

1.7

2.1

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

273

1.36

1.00

1.7

2.1

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

736

1.21

1.00

1.1

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

133

1143

1.17

0.98

1.3

1.5

u/ml

104.7

120.5

1.30

249

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

107

903

1.19

0.97

1.1

127.2

117.6

2.27

810

(3000012) Reticulocyte production index

353

1.30

0.97

1.3

1.5

—

(3013862) HLA-DP [Type]

0.00

0.97

0.0

1.0

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

219

2452

0.89

0.95

1.4

1.3

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

770

0.80

0.95

1.5

1.4

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

149

1.48

0.95

1.3

1.2

pmol/l

358.5

332.1

0.05

106

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

769

0.80

0.94

1.5

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

769

0.80

0.94

1.5

1.4

—

(4133840)

166

1.45

0.94

1.2

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

453

1.26

0.93

1.5

1.8

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.73

0.92

2.0

2.1

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

127

1.50

0.88

1.1

1.3

—

(3020393) Adenovirus Ag [Presence] in Stool

1.79

0.87

1.0

1.1

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

1.58

0.87

1.3

ng/l

76.1

83.6

—

(3051593) INR in Capillary blood by Coagulation assay

290

1.31

0.86

15.5

12.0

—

(3029075) Extractable nuclear Ab panel - Serum

178

1.41

0.86

1.1

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.82

0.85

1.3

1.2

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

414

1.26

0.85

1.0

1.1

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

308

1.30

0.85

1.1

—

(3000285) Sodium [Moles/volume] in Blood

1.63

0.84

1.2

1.1

—

(3046861) Legionella sp Ag [Presence] in Urine

1.94

0.84

1.2

1.1

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.94

0.84

1.0

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

647

0.80

0.84

1.5

1.4

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

137

1.46

0.83

1.1

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

179

1.40

0.83

2.2

1.9

—

(3004775) Volume in Urine collected for unspecified duration

546

0.79

0.83

2.2

2.3

613.7

663.0

0.41

385

(3008116) Ketones [Moles/volume] in Urine by Test strip

129

1.47

0.83

2.3

1.3

—

(3015183) Erythrocyte sedimentation rate

283

1.31

0.83

1.2

—

(3012441) Differential panel - Pleural fluid

689

0.81

0.82

1.5

1.4

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

301

1.30

0.82

2.0

2.1

ug/min

30.8

156.1

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

417

1.25

0.81

1.0

1.1

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

764

1.18

0.81

1.1

—

(3051651) Icteric interference index of Serum or Plasma

420

0.76

0.80

3.6

3.5

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

701

1.19

0.79

1.8

1.6

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

773

0.83

0.79

2.6

2.0

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

838

0.83

0.79

1.5

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

1.82

0.79

10.3

8.6

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

235

0.68

0.78

1.0

1.1

—

(3012898) Urea [Moles/volume] in Urine

1.67

0.78

1.4

1.3

mmol/l

172.8

147.0

0.31

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

140

1.43

0.76

1.1

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

1.77

0.76

1.3

1.1

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.77

0.76

1.0

—

(40760410) HLA-B [Type] by High resolution

0.00

0.76

0.0

1.0

—

(40763590) HLA-DQ beta [Type]

0.00

0.76

0.0

1.0

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.76

0.0

1.0

—

(46236302) HLA-C [Type] by High resolution typing

0.00

0.76

0.0

1.0

—

(40760409) HLA-A [Type] by High resolution

0.00

0.76

0.0

1.0

—

(3028433) Virus identified in Specimen by Culture

226

1.33

0.76

1.1

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

200

1805

1.11

0.75

1.3

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

219

1986

1.11

0.75

2.4

2.1

91.1

91.0

0.01

198

1844

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

332

1.27

0.75

2.2

2.1

u/l

223.6

204.7

0.63

327

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

458

1.22

0.75

1.5

1.3

pmol/l

96.3

62.9

0.77

137

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

227

1.32

0.74

1.6

1.7

—

(3020874) Milk IgE Ab [Units/volume] in Serum

334

1.26

0.73

1.0

u/ml

0.5

2.7

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

2.00

0.72

1.0

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

142

1.41

0.72

1.1

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.55

0.71

1.2

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

1.62

0.71

1.3

1.1

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

129

1140

1.13

0.71

1.1

1.3

u/ml

295.9

294.7

0.02

725

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

229

0.70

1.9

1.8

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.71

0.70

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.51

0.69

1.1

1.3

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.51

0.69

1.1

1.3

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.51

0.69

1.1

1.3

—

(3032057) Clostridioides difficile [Presence] in Stool

135

1.41

0.68

1.9

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

1.60

0.68

1.4

1.3

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.60

0.68

1.1

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

201

1829

1.10

0.67

2.8

2.3

176.2

194.6

2.44

187

1735

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

119

1.43

0.66

1.4

1.5

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

226

0.71

0.66

1.0

1.1

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

103

903

1.14

0.65

1.0

1.1

g/l

1.6

1.5

0.57

819

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

1.61

0.65

1.0

1.1

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

1.72

0.64

1.4

1.7

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

112

1.43

0.63

1.1

—

(3005033) Fetal Nuchal fold Thickness US

643

0.84

0.62

1.5

1.4

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

324

1.24

0.62

1.1

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

288

1.25

0.62

1.0

—

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

0.00

0.60

0.0

1.2

—

(3011544) Albumin [Mass/volume] in Pleural fluid

1.51

0.58

1.0

1.2

g/l

13.4

17.2

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

1.71

0.57

1.3

1.5

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

561

0.84

0.57

1.7

1.5

g/l

0.9

1.0

1.64

561

(3033799) Differential panel - Peritoneal fluid

241

0.75

0.56

1.3

1.8

—

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

1.43

0.56

3.8

3.6

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.51

0.56

1.6

2.8

u/field

0.5

0.7

0.31

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

150

1.33

0.55

1.1

1.0

—

(4212803)

1.50

0.54

1.1

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.50

0.54

2.0

1.9

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.41

0.54

1.0

1.1

—

(3051611) Lipemic interference index of Serum or Plasma

711

1.14

0.54

3.3

3.2

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

341

1.20

0.52

1.2

1.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

120

1084

1.11

0.51

1.2

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

135

1.33

0.51

1.1

u/ml

0.3

1.6

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

109

1.38

0.50

3.3

3.5

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

101

1.39

0.49

1.2

1.0

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

433

4119

1.05

0.49

3.0

3.9

u/ml

32.9

66.6

3.02

409

3964

(3035880) pH of Pleural fluid

335

1.19

0.48

1.3

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

1.45

0.48

1.0

—

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

1.49

0.47

1.4

1.7

pmol/l

10.2

19.9

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

155

1.29

0.46

1.0

1.3

g/l

21.7

24.8

0.44

120

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

221

0.77

0.46

1.4

1.9

—

(3000330) Specific gravity of Urine by Test strip

340

3225

1.06

0.44

3.2

3.3

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

192

1.25

0.44

3.7

2.3

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

192

1.25

0.44

3.6

2.3

—

(3025130) Human papilloma virus identified in Specimen

875

1.11

0.44

1.6

1.7

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

311

1.19

0.44

1.2

1.6

—

(3008536) Aspergillus sp Ab [Presence] in Serum

121

1.32

0.44

1.1

2.3

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

193

1.24

0.43

2.2

1.5

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

258

2431

1.06

0.43

1.9

1.7

mg/l

3.6

0.07

201

1700

(3043238) Trisomy 21 risk [Likelihood] in Fetus

671

0.88

0.43

1.5

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

1.56

0.42

1.0

1.5

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.43

0.41

1.0

1.2

—

(4268621)

633

1.12

0.41

2.2

—

(42868555) Amyloid beta 40 peptide [Mass/volume] in Cerebral spinal fluid

0.00

0.40

0.0

1.0

—

13103.8

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

183

0.76

0.40

1.3

1.5

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

141

1.28

0.40

1.1

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

114

1045

1.09

0.39

2.9

2.7

u/ml

6673.9

2520.4

—

(3045142) Bone marrow Pathology biopsy report

761

0.89

0.39

1.3

1.4

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

826

1.10

0.39

1.3

1.4

nmol/l

0.4

0.3

0.33

610

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

106

1.32

0.39

1.1

1.2

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

160

1.25

0.38

1.1

1.2

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

160

1.25

0.38

1.2

1.3

26.7

18.8

0.51

142

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

243

1.19

0.37

1.0

1.1

miu/ml

1872.3

1527.4

0.68

243

(3014599) Egg white IgE Ab [Units/volume] in Serum

337

1.16

0.36

1.0

u/ml

0.5

0.9

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

162

1.24

0.35

1.2

—

(21494814) CD8 cells/100 lymphocytes in Specimen

276

0.83

0.34

1.7

1.9

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

319

0.85

0.34

1.1

1.2

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

189

1783

1.06

0.33

2.6

3.2

mg/l

1.5

0.02

176

1637

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

151

1415

1.07

0.33

1.5

—

(3014271) Vancomycin [Susceptibility]

275

1.16

0.32

2.7

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

243

2553

0.95

0.32

2.8

3.7

u/ml

102.2

1387.9

2.77

206

2187

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

388

1.13

0.32

1.1

u/l

19.6

24.2

0.48

292

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

1.35

0.32

2.9

3.6

mg/l

1.3

1.1

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

146

1.23

0.32

1.1

1.2

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

229

1.18

0.32

1.5

mmol/l

7.9

8.2

0.29

136

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

257

1.17

0.32

2.2

1.8

—

(3024471) HLA-A [Type]

241

0.83

0.31

1.0

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

276

1.16

0.31

2.1

2.4

umol/l

53.9

54.7

0.05

224

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

389

1.13

0.31

1.1

u/l

80.9

85.9

0.25

303

(3020491) Glucose [Moles/volume] in Blood

456

1.12

0.31

1.6

2.1

mmol/l

7.0

6.8

0.25

305

(3025549) Creatine [Moles/time] in 24 hour Urine

1.30

0.30

2.0

1.4

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.30

0.30

1.3

1.2

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

667

1.10

0.30

1.2

1.1

103.1

96.5

1.19

622

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

129

1.24

0.30

1.1

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

203

1.18

0.29

1.3

1.2

—

(3043410) Blood group antigens tested for on Red Blood Cells

166

1.21

0.29

1.5

1.9

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1077

10554

1.02

0.29

2.8

2.9

ug/l

0.7

0.8

1.56

709

6776

(3027035) Albumin [Mass/time] in 24 hour Urine

1.25

0.29

1.4

—

309.2

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.32

0.28

1.7

2.6

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.29

0.28

1.2

—

(3044007) Cell count panel - Peritoneal fluid

205

0.83

0.28

1.4

1.8

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

489

1.10

0.27

1.5

1.6

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

140

1.21

0.27

2.2

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

737

7542

0.97

0.26

3.0

4.3

ug/l

7.1

29.3

3.78

605

6084

(3051387) C reactive protein [Mass/volume] in Capillary blood

139

1471

0.94

0.26

4.3

3.2

mg/l

28.2

27.5

0.07

929

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

549

1.09

0.25

1.1

—

(3024932) HLA-DR beta [Type]

235

0.85

0.25

1.0

1.1

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

358

1.12

0.25

1.6

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

359

1.11

0.24

1.6

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

0.74

0.24

6.0

6.8

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.73

0.24

3.0

3.4

—

(3005011) Chlamydia sp Ab [Titer] in Serum

0.73

0.24

1.5

1.7

—

(3026250) Tacrolimus [Mass/volume] in Blood

307

0.88

0.23

30.7

34.8

ug/l

7.4

7.3

0.09

279

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

1.28

0.23

1.8

4.0

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.24

0.22

1.9

1.5

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

844

1.07

0.22

1.1

u/ml

1.9

3.1

1.21

408

(44806071)

1.27

0.22

1.1

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1.22

0.22

1.0

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

191

1.15

0.21

1.3

1.2

ug/l

186.5

321.3

0.35

109

(3007463) Buprenorphine [Presence] in Urine

0.00

0.21

0.0

4.9

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.21

0.0

1.0

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.21

0.0

2.9

—

(3007919) Fasciola sp Ab [Titer] in Serum

0.00

0.21

0.0

1.0

—

(3018291) Platelet Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

0.21

0.0

1.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

296

1.12

0.21

1.2

1.1

—

(3018834) Bilirubin.total [Presence] in Urine by Test strip

1.16

0.21

4.0

3.7

—

0.0

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

139

1457

0.95

0.21

1.5

—

(3017958) Strawberry IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.1

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

0.00

0.20

0.0

6.0

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

137

1310

1.05

0.19

1.7

1.9

nmol/l

0.8

0.11

116

1094

(3015076) Soybean IgE Ab [Units/volume] in Serum

308

1.10

0.19

1.0

u/ml

0.2

2.1

—

(40765096) Chromosome analysis panel by Banding

205

0.88

0.17

1.3

1.1

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

0.76

0.17

1.0

1.2

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.75

0.17

1.2

1.1

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

392

0.92

0.16

1.1

1.2

—

(3003434) Protein [Mass/volume] in Pleural fluid

863

0.95

0.16

1.4

g/l

34.1

33.5

0.16

789

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

1.10

0.15

1.0

1.1

—

(4146454)

709

0.94

0.15

3.0

2.7

—

(3003740) Influenza virus B Ag [Presence] in Specimen

964

0.95

0.15

1.1

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.80

0.14

1.4

1.5

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

460

0.93

0.14

1.5

1.6

ug/l

3.2

4.8

0.57

359

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

386

0.93

0.12

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

472

1.06

0.12

4.9

6.4

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

317

1.07

0.12

4.3

3.7

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

668

0.96

0.10

2.4

2.5

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

678

0.96

0.10

1.5

1.4

e6/l

27309.0

49551.2

0.84

382

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

647

0.96

0.10

1.2

—

(3009871) Measles virus Ab [Titer] in Serum

222

1.08

0.10

1.6

1.7

—

(3002523) Influenza virus A Ag [Presence] in Specimen

961

0.97

0.10

1.1

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.09

0.09

8.8

4.5

—

(3016750) Collection duration of Urine

391

0.95

0.09

1.9

2.2

min

507.2

497.7

0.25

305

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

155

0.90

0.09

1.3

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.09

0.08

1.8

2.4

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

938

0.97

0.08

4.6

5.4

umol/l

349.4

375.8

0.87

800

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

410

1.05

0.08

1.6

1.5

—

(3036071) Salmonella sp Ab [Titer] in Serum

175

1.09

0.08

1.1

—

(40765089) Chromosome analysis panel - Blood by G-banded

113

0.88

0.08

1.0

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

0.81

0.08

7.6

10.1

—

(3002256) Pathology report gross observation

923

9162

1.01

0.08

1.3

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

598

1.04

0.08

1.6

1.7

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

323

1.05

0.07

1.4

1.3

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

1.07

0.07

4.6

3.5

umol/l

41.4

40.6

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

0.85

0.06

1.0

1.1

mg/g

6.6

6.8

—

(3011648) Oxygen content in Venous blood

502

1.04

0.06

1.8

2.4

10.6

11.1

0.41

502

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

103

0.87

0.06

1.0

1.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

671

1.03

0.06

1.3

—

(40768441) Liver Pathology biopsy report

527

0.97

0.06

1.3

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

168

1.07

0.06

1.2

1.1

—

(3034426) Prothrombin time (PT)

208

1.06

0.05

1.3

1.2

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

161

0.93

0.05

1.9

ug/l

3.6

2.2

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

110

1.09

0.05

1.0

1.3

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

333

0.96

0.05

1.1

1.2

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

201

0.95

0.04

1.3

1.1

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

298

1.04

0.04

1.4

1.6

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

298

1.04

0.04

1.4

1.6

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

102

1003

1.02

0.04

1.1

iu/ml

22.0

822.0

0.78

225

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

685

0.98

0.04

1.4

1.5

—

(3042733) HLA Ab [Presence] in Serum

229

1.05

0.04

3.1

5.1

—

(3023199) Leukocytes [#/volume] in Pleural fluid

757

1.02

0.03

1.5

e6/l

3472.1

2813.8

0.16

540

(3050129) First trimester maternal screen panel - Serum or Plasma

951

0.99

0.02

1.4

—

(3035933) Granulocytes/100 leukocytes in Blood

177

0.96

0.01

1.9

1.7

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

183

1.04

0.01

1.1

1.3

g/l

9.4

12.6

0.95

148

(40768446) Kidney Pathology biopsy report

277

0.97

0.01

1.5

1.6

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

507

0.99

0.01

1.4

1.5

—

(3045788) Cell count panel - Pleural fluid

587

0.99

0.01

1.5

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

1.06

0.01

1.0

1.4

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

224

1.03

0.00

2.0

1.7

e6/l

9359.4

17906.3

0.35

119

(40758292) HTLV I+II Ab panel - Serum

103

0.97

0.00

1.3

1.5

—

(21494815) CD4 cells/100 lymphocytes in Specimen

557

1.01

0.00

1.6

2.3

41.9

39.2

—

(3041806) Other cells [#/volume] in Blood by Manual count

102

0.98

0.00

1.9

1.4

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

172

0.99

0.00

1.8

1.9

u/l

110.5

27.1

0.39

154

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

821

1.00

0.00

1.6

1.9

ug/l

22.2

24.5

0.21

807

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

139

1.01

0.00

1.1

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

0.00

0.0

1.0

—

(3027859) Formaldehyde IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

0.00

0.0

1.1

—

(3025566) Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

0.0

1.1

—

(3043614) Bacteria identified in Aspirate by Culture

0.00

0.0

1.0

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

0.00

0.0

1.4

—

82.3

—

(40758047) Lysozyme [Mass/volume] in Pleural fluid

0.91

0.00

1.0

1.1

mg/l

10.8

9.8

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

0.92

0.00

15.0

9.8

mmol/l

3.6

5.5

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.0

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

0.85

0.00

1.0

1.1

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

0.00

0.0

5.2

—

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.0

1.0

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

0.98

0.00

1.0

2.1

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.0

1.0

—

(3020093) Fractional oxyhemoglobin in Venous cord blood

0.00

0.0

1.2

—

61.1

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

0.98

0.00

5.0

4.1

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.0

1.1

—

(3036180) Methadone [Presence] in Urine

0.00

0.0

3.2

—

(3016976) Cortisol [Moles/volume] in Serum or Plasma --baseline

0.00

0.0

1.0

—

310.0

—

(3009992) Blasts/100 cells in Bone marrow

0.00

0.0

2.3

—

2.8

—

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3000876) Codfish IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3046594) Interleukin 8 [Mass/volume] in Serum or Plasma

0.00

0.0

1.0

—

37.7

—

(3022475) Manganese [Moles/volume] in Blood

1.02

0.00

1.2

1.3

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

0.0

1.2

—

2458.3

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.92

0.00

1.0

—

(3036005) Urine sediment comments by Light microscopy Narrative

0.00

0.0

1.2

—

(3022670) pH of Venous cord blood

0.00

0.0

1.2

—

(3017509) Phencyclidine [Presence] in Urine

0.96

0.00

1.0

1.6

—

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

0.0

1.2

—

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

0.00

0.0

1.0

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.94

-0.00

1.2

1.1

—

Mortality – FinRegistry

↥

Association

Association between endpoint M13_SPONDYLOLISTHESIS and mortality.

Females

Parameter	HR [95% CI]	p-value
M13_SPONDYLOLISTHESIS	0.957 [0.86, 1.07]	0.426
Birth year	0.995 [0.99, 1.0]	0.204

During the follow-up period (1.1.1998 — 31.12.2019), 2409 out of 24174 females with M13_SPONDYLOLISTHESIS died.

Males

Parameter	HR [95% CI]	p-value
M13_SPONDYLOLISTHESIS	1.056 [0.95, 1.18]	0.323
Birth year	0.989 [0.98, 1.0]	0.018

During the follow-up period (1.1.1998 — 31.12.2019), 1963 out of 16826 males with M13_SPONDYLOLISTHESIS died.

Mortality risk

Mortality risk for people of age

years, who have M13_SPONDYLOLISTHESIS.

N-year risk	Females	Males
1	0.082%	0.238%
5	0.591%	1.269%
10	1.443%	3.212%
15	2.637%	6.173%
20	4.882%	10.728%

Relationships between endpoints

↥

Index endpoint: M13_SPONDYLOLISTHESIS – Spondylolisthesis/Spondylolysis

GWS hits: 7

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Spondylolisthesis/Spondylolysis

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints